Neuroendocrine Tumors
Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
Carcinoma, Neuroendocrine
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
Carcinoma
Neurosecretory Systems
Neuroendocrine Cells
Specialized NEURONS that produce hormones, such as NEUROPEPTIDES or BIOGENIC AMINES. They generally are in the NERVOUS SYSTEM, such as HYPOTHALAMUS, but can be found in other organs or systems. These neurons contain dense neurosecretory granules and PROPROTEIN CONVERTASES allowing the rapidly release of NEUROHORMONES into the blood circulation upon stimulation.
Carcinoma, Squamous Cell
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
Chromogranin A
A type of chromogranin which was first isolated from CHROMAFFIN CELLS of the ADRENAL MEDULLA but is also found in other tissues and in many species including human, bovine, rat, mouse, and others. It is an acidic protein with 431 to 445 amino acid residues. It contains fragments that inhibit vasoconstriction or release of hormones and neurotransmitter, while other fragments exert antimicrobial actions.
Carcinoma in Situ
Chromogranins
A group of acidic proteins that are major components of SECRETORY GRANULES in the endocrine and neuroendocrine cells. They play important roles in the aggregation, packaging, sorting, and processing of secretory protein prior to secretion. They are cleaved to release biologically active peptides. There are various types of granins, usually classified by their sources.
Carcinoid Tumor
A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
Carcinoma, Papillary
Immunohistochemistry
Carcinoma, Small Cell
Carcinoma, Ductal, Breast
Carcinoma, Basal Cell
A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
Tumor Markers, Biological
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Neuroendocrine Secretory Protein 7B2
Carcinoma, Large Cell
Carcinoma, Medullary
A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)
Carcinoma, Merkel Cell
A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. (Holland et al., Cancer Medicine, 3d ed, p1245)
Gastrointestinal Neoplasms
Carcinoma, Bronchogenic
Carcinoma, Transitional Cell
Synaptophysin
Prognosis
Octreotide
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Adenoid Cystic
Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)
Neoplasm Staging
Gene Expression Regulation, Neoplastic
Tumor Cells, Cultured
Carcinoma, Lobular
A infiltrating (invasive) breast cancer, relatively uncommon, accounting for only 5%-10% of breast tumors in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1205)
Receptors, Somatostatin
Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter.
Carcinoma, Mucoepidermoid
A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)
Lymphatic Metastasis
Neoplasm Metastasis
RNA, Messenger
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Head and Neck Neoplasms
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
Hypothalamo-Hypophyseal System
A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS.
Neoplasms, Multiple Primary
Carcinoma, Endometrioid
Somatostatin
A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.
Retrospective Studies
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Hypothalamus
Neoplasm Proteins
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Carcinoma, Embryonal
A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)
Treatment Outcome
Immunoenzyme Techniques
Carcinoma, Ductal
Ovarian Neoplasms
Chromogranin B
A type of chromogranin which was initially characterized in a rat PHEOCHROMOCYTOMA CELL LINE. It is found in many species including human, rat, mouse, and others. It is an acidic protein with 626 to 657 amino acid residues. In some species, it inhibits secretion of PARATHYROID HORMONE or INSULIN and exerts bacteriolytic effects in others.
Mice, Nude
Laryngeal Neoplasms
Phosphopyruvate Hydratase
Adrenocortical Carcinoma
A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.
Neoplasm Recurrence, Local
Carcinoma, Verrucous
A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30% treated with radiation become highly aggressive within six months. (Segen, Dictionary of Modern Medicine, 1992)
Reverse Transcriptase Polymerase Chain Reaction
Carcinoma, Signet Ring Cell
Survival Rate
Survival Analysis
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Pituitary-Adrenal System
Fatal Outcome
Adenocarcinoma, Mucinous
Tomography, X-Ray Computed
Adrenocorticotropic Hormone
An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP).
Neoplasm Transplantation
Hydrocortisone
Disease Progression
Ki-67 Antigen
Antigens, Neoplasm
Neuropeptides
Carcinoma, Non-Small-Cell Lung
Combined Modality Therapy
Keratins
A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.
Endocrine Glands
Corticosterone
Tumor Suppressor Protein p53
Precancerous Conditions
Adenocarcinoma, Follicular
Vipoma
A tumor that secretes VASOACTIVE INTESTINAL PEPTIDE, a neuropeptide that causes VASODILATION; relaxation of smooth muscles; watery DIARRHEA; HYPOKALEMIA; and HYPOCHLORHYDRIA. Vipomas, derived from the pancreatic ISLET CELLS, generally are malignant and can secrete other hormones. In most cases, Vipomas are located in the PANCREAS but can be found in extrapancreatic sites.
Signal Transduction
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Common Bile Duct Neoplasms
Proprotein Convertase 2
Apoptosis
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
Biopsy
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Tissue Array Analysis
Cell Differentiation
Disease-Free Survival
Ampulla of Vater
Carcinoma, Islet Cell
Embryonal Carcinoma Stem Cells
Colorectal Neoplasms
Radiopharmaceuticals
Follow-Up Studies
Base Sequence
Mutation
Secretory Vesicles
Cell Division
Kaplan-Meier Estimate
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
Carcinoma, Papillary, Follicular
Pheochromocytoma
A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
Chemoembolization, Therapeutic
Gastrinoma
A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).
Blotting, Western
Cell Transformation, Neoplastic
Endometrial Neoplasms
Cisplatin
An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.
Adenocarcinoma, Clear Cell
An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)
Nervous System Neoplasms
Corticotropin-Releasing Hormone
A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS.
Small Cell Lung Carcinoma
Endocrine System Diseases
alpha-Fetoproteins
Pituitary Gland
Loss of Heterozygosity
Sensitivity and Specificity
Gene Expression
Cystadenocarcinoma, Serous
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
Carcinoma, Lewis Lung
A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
PC12 Cells
Antineoplastic Combined Chemotherapy Protocols
Hyperplasia
Neuroimmunomodulation
Neoplasm Grading
Gene Expression Profiling
In Situ Hybridization
Tumor Burden
Apudoma
Insulinoma
Pituitary Hormones
Hormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS.
Transfection
Hormones
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.
Prolactin
A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.
Pro-Opiomelanocortin
A 30-kDa protein synthesized primarily in the ANTERIOR PITUITARY GLAND and the HYPOTHALAMUS. It is also found in the skin and other peripheral tissues. Depending on species and tissues, POMC is cleaved by PROHORMONE CONVERTASES yielding various active peptides including ACTH; BETA-LIPOTROPIN; ENDORPHINS; MELANOCYTE-STIMULATING HORMONES; and others (GAMMA-LPH; CORTICOTROPIN-LIKE INTERMEDIATE LOBE PEPTIDE; N-terminal peptide of POMC or NPP).
Neoplasms, Nerve Tissue
Glucagonoma
Neovascularization, Pathologic
Genes, p53
Paraganglioma
A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)
Transcription Factors
Chromaffin Cells
Cells that store epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia (PARAGANGLIA, CHROMAFFIN) of the sympathetic nervous system.
Calcitonin
Carcinoembryonic Antigen
Neurosecretion
Yttrium Radioisotopes
Cadherins
Calcium-dependent cell adhesion proteins. They are important in the formation of ADHERENS JUNCTIONS between cells. Cadherins are classified by their distinct immunological and tissue specificities, either by letters (E- for epithelial, N- for neural, and P- for placental cadherins) or by numbers (cadherin-12 or N-cadherin 2 for brain-cadherin). Cadherins promote cell adhesion via a homophilic mechanism as in the construction of tissues and of the whole animal body.
Oxytocin
Receptor, erbB-2
A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.
Positron-Emission Tomography
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
Gonadotropin-Releasing Hormone
A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.
Phenotype
Adenocarcinoma, Papillary
Down-Regulation
Tumor Suppressor Proteins
Genes, Tumor Suppressor
Carcinoma, Pancreatic Ductal
Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin. (1/327)
The survival of 64 consecutive patients with disseminated midgut carcinoid tumours was compared in a retrospective study with that of 25 consecutive patients with sporadic malignant endocrine pancreatic tumours treated according to similar surgical principles. The presence of hepatic metastases implied a worse prognosis in neuroendocrine tumours of pancreatic rather than midgut origin. This infers that these tumour types must be separated when treatments are evaluated. (+info)Brain metastases from adenoendocrine carcinoma of the common bile duct: a case report. (2/327)
A 68-year-old man with metastatic brain tumors from adenoendocrine carcinoma of the common bile duct is reported. A common bile duct tumor and a metastatic liver tumor had been resected 6 years and 3 years prior to admission, respectively. Microscopically they showed two components; moderately differentiated tubular adenocarcinoma and neuroendocrine carcinoma. He presented with headache and vomiting and MRI revealed two metastatic brain tumors. They were successfully resected and radiotherapy was carried out. Histological diagnosis of the metastatic brain tumors was neuroendocrine carcinoma, but carbohydrate antigen (CA)-19-9 and carcinoembryonic antigen (CEA)-immunoreactive cells were observed without glandular pattern. Immunohistochemically serotonin and pancreatic polypeptide were detected, but somatostatin was not. As the endocrine cells demonstrated in the normal extrahepatic bile ducts are only somatostatin-containing D cells, these cells are considered to originate as part of a metaplastic process. To our knowledge, this represents the second case of adenoendocrine carcinoma of the common bile duct. (+info)Thymic carcinoma with neuroendocrine differentiation in a calf. (3/327)
A neuroendocrine carcinoma originating in the thymus was found in a 7-month-old, castrated male, Japanese Black calf. The neoplasm consisted largely of very primitive cells, characterized by the paucity of cytoplasmic organelles, but a few cells were immunoreactive for somatostatin or neurofilaments. The expression of both cytokeratin and neurofilament protein was a feature of neuroendocrine differentiation. This neoplasm considered to be a tumor of a thymic stem cell, with little but indubitable evidence of differentiation into somatostatin-producing cells. (+info)Relationship of ECL cells and gastric neoplasia. (4/327)
The enterochromaffin-like (ECL) cell in the oxyntic mucosa has a key role in the regulation of gastric secretion since it synthesizes and releases the histamine regulating the acid secretion from the parietal cell. Gastrin is the main regulator of the ECL cell function and growth. Long-term hypergastrinemia induces ECL cell hyperplasia, and if continued, neoplasia. ECL cell carcinoids occur in man after long-term hypergastrinemia in conditions like pernicious anemia and gastrinoma. There is also accumulating evidence that a proportion of gastric carcinomas of the diffuse type is derived from the ECL cell. Furthermore, the ECL cell may, by producing substances with angiogenic effects (histamine and basic fibroblast growth factor), be particularly prone to develop malignant tumors. Although the general opinion is that gastrin itself has a direct effect on the oxyntic mucosal stem cell, it cannot be excluded that the general trophic effect of gastrin on the oxyntic mucosa is mediated by histamine or other substances from the ECL cell, and that the ECL cell, therefore, could play a role also in the tumorigenesis/carcinogenesis of gastric carcinomas of intestinal type. (+info)Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression. (5/327)
The plasminogen activator cascade initiated by urokinase type plasminogen activator (u-PA) is involved in extracellular matrix degradation during the tumor invasion process. The plasminogen activator inhibitors 1 (PAI-1) and 2 (PAI-2) are two specific inhibitors of u-PA. We hypothesized that the balance between u-PA and its two inhibitors could be disrupted to favor plasminogen activation during lung cancer progression. Using immunohistochemistry, we analyzed the pattern of expression of u-PA, PAI-1, and PAI-2 in non-small cell lung carcinomas (NSCLC) and neuroendocrine (NE) lung tumors. u-PA and PAI-1 were both detected in stromal fibroblasts and in tumor cells. In 84 NSCLCs, their epithelial expression was strongly correlated and linked to the presence of node metastasis (P = 0.008), whereas their coexpression in fibroblasts was associated with larger tumor size (P = 0.04) and advanced stages (P = 0.009). In 72 NE tumors, u-PA and PAI-1 were more frequently expressed in fibroblasts in high-grade NE tumors (SCLC and large cell NE tumors) than in low- and intermediate-grade tumors (typical and atypical carcinoids). Comparison of in situ hybridization and immunohistochemistry in 14 cases showed that PAI-1 was consistently expressed by stromal fibroblasts, although the protein was also localized in tumor cells. In contrast, the expression of PAI-2 was restricted to fibroblasts and correlated with the absence of nodal involvement (P = 0.005). Considering NE tumors, the frequency of PAI-2 expression decreased along the NE spectrum from typical carcinoids to SCLCs. These data suggest that PAI-lacts in synergy with u-PA to favor tumor invasion process and connotes aggressivity, in contrast with PAI-2, which may block u-PA-mediated proteolysis and is inversely correlated with tumor progression. (+info)Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung. (6/327)
In order to test the hypothesis that increased apoptotic activity is connected with neuroendocrine differentiation and low differentiation degree in large cell carcinoma (LCLC) and is regulated by bcl-2 family proteins, we analysed the extent of apoptosis and tumor necrosis and their relation to the expression of bcl-2, bax, bak and mcl-1 in 35 LCLCs, of which 20 were classified as large cell neuroendocrine lung carcinomas (LCNEC) and 15 as large cell non-neuroendocrine lung carcinomas (LCNNEC). The extent of apoptosis was determined by detecting and counting the relative and absolute numbers of apoptotic cells and bodies using in situ 3 -end labelling of the apoptotic DNA. The extent and intensity of expression of the bcl-2, bax, bak and mcl-1 proteins were studied by immunohistochemistry. Also the relative volume density of necrosis was evaluated and correlated with the other parameters. Finally, all the parameters were evaluated as prognostic markers and correlated with data on the survival of the patients. Relatively high apoptotic indices were seen in both tumor types (average for both 2.53%, range 0.09 27.01%). Significantly higher bcl-2 and bak indices were detected more often in LCNECs than in LCNNECs. Immunohistochemically detected bax, bcl-2 and bak expression was independent of apoptotic index in both tumor types, while there was a statistically significant positive association between mcl-1 expression and apoptotic index in LCNNEC but not in LCNEC. There was a statistically significant association between high apoptotic index and shortened survival in LCLC. However, no association was found between tumor stage and apoptosis. The patients with LCNEC and low bcl-2 protein expression had a significantly shorter survival time than those with high bcl-2 indices. There was also a clear association between shortened survival and necrotic LCNNEC. LCLCs show relatively high apoptotic activity, which is associated with shortened survival. The expression of bcl-2, bak and mcl- 1 is associated with neuroendocrine differentiation in LCLC. Finally, our results support some previous reports suggesting that bcl-2 expression in combination with some other markers involved in apoptosis and/or proliferation may be of prognostic value in cases of lung carcinoma with neuroendocrine differentiation. (+info)Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. (7/327)
Semaphorins/collapsins are a family of secreted and membrane-associated proteins involved in nerve growth cone migration. However, some are expressed widely in adult tissues suggesting additional functions. SEMA3F/H.SemaIV was previously isolated from a 3p21.3 homozygous deletion region in human lung cancer. We studied SEMA3F cellular localization using our previously characterized anti-SEMA3F antibody. In normal lung, SEMA3F was found in all epithelial cells at the cytoplasmic membrane and, to a lesser extent, in the cytoplasm. In lung tumors, the localization was predominantly cytoplasmic, and the levels were comparatively reduced. In non-small-cell lung carcinomas, low levels correlated with higher stage. In all tumors, an exclusive cytoplasmic localization of SEMA3F correlated with high levels of vascular endothelial growth factor and was related to the grade and aggressiveness. This suggests that vascular endothelial growth factor might compete with SEMA3F for binding to their common receptors, neuropilin-1 and -2 and might contribute to SEMA3F delocalization and deregulation in lung tumor. In parallel studies, SEMA3F distribution was examined in cell cultures by confocal microscopy. Marked staining was observed in pseudopods and in the leading edge or ruffling membranes of lamellipods or cellular protrusions in motile cells. SEMA3F was also observed at the interface of adjacent interacting cells suggesting a role in cell motility and cell adhesion. (+info)Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma. A clinicopathologic and immunohistochemical study of 11 cases. (8/327)
We reviewed 11 cases of primary thymic neuroendocrine carcinomas with combined features ranging from well-differentiated to poorly differentiated neuroendocrine carcinoma. For 3 asymptomatic patients, tumors were discovered during routine examination. Presentation in the other patients was as follows: Cushing syndrome, 2 patients; chest pain, 3 patients; superior vena cava syndrome, 1 patient; and hypercalcemia and hypophosphatemia, 1 patient. No clinical data were available for the 11th patient. All tumors were located in the anterior mediastinum and treated by surgical excision. The lesions were large and well-circumscribed with areas of hemorrhage and necrosis. They were characterized by areas showing a proliferation of monotonous, round tumor cells adopting a prominent organoid pattern admixed with areas showing sheets of atypical cells with hyperchromatic nuclei, frequent mitoses, and extensive areas of hemorrhage and necrosis. Immunohistochemical studies performed in 6 cases showed strong CAM 5.2 low-molecular-weight cytokeratin positivity in all cases, chromogranin and synaptophysin positivity in 4, Leu-7 in 3, and focal positivity for p53 in 2. Follow-up information for 9 cases showed that all patients died of their tumors between 1 and 4 years after diagnosis. The present cases highlight the heterogeneity of neuroendocrine neoplasms and reinforce the notion that these tumors form part of a continuous spectrum of differentiation. (+info)
Large cell neuroendocrine carcinoma presenting with neck swelling in the submandibular gland: a case report | Journal of...
ESMO 2017: Improved Survival Demonstrated with NSCLC-chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma with RB1...
Chemotherapy Effective For Patients With Resected SCLC Or Large-Cell Neuroendocrine Carcinoma - Redorbit
Primary neuroendocrine carcinoma of the breast: a 5-year experiences.
Analysis of Protein Expression and Gene Mutation of c-kit in Colorectal Neuroendocrine Carcinomas<...
Large Cell & Small Cell Gastrointestinal Neuroendocrine Carcinoma | Memorial Sloan Kettering Cancer Center
Primary small cell neuroendocrine carcinoma of the kidney.
Primary neuroendocrine carcinoma of the brain | BMJ Case Reports
Cisplatin Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the...
Cisplatin Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the...
Cervical Large Cell Neuroendocrine Carcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma ...
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers<...
Expression of 4F2hc (CD98) in pulmonary neuroendocrine tumors
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Foreca... ( NEW YORK May 15 2012 /- Reportlinker....)
The new World Health Organization classification of lung tumours | European Respiratory Society
Primary combined small cell carcinoma of larynx with lateralized histologic components and corresponding sidespecific neck...
Synchronous two distinct neuroendocrine lung cancer lesions | Rydel | Advances in Respiratory Medicine
CMU Intellectual Repository: Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma...
lungNENomics - Rare Cancers Genomics
Most recent papers with the keyword Carcinoid tumor | Read by QxMD
Value of Cytology in Small Cell Lung Carcinoma Diagnostic - Single-Center Study
Plus it
Multimodality Treatment for Thymic Carcinoma: Review of 11 Cases at a Single Institute
Post-operative outcomes in non-small cell lung cancer patients with mild to moderate stage chronic obstructive pulmonary...
International Classification of Diseases for Oncology: Morphology of Neoplasms, Edition 3 (2000)
ENETS Abstract library
ENETS Abstract library
Jupyter Notebook Viewer
Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results ...
Current Advances in Diagnosis of Hepatic Metastases from Neuroendocrine Carcinomas | OMICS International
New video Neuroendocrine carcinomas (NEC) outside the lungs | NET Cancer Day
Clinicopathologic features of primary renal neuroendocrine carcinoma]
All Specialist in Neuroendocrine Carcinoma messages
Systematic review and two new cases of primary upper urinary tract neuroendocrine carcinomas.
What has been COVID-19 Impact on Neuroendocrine Carcinoma Treatment Market? - PharmiWeb.com
Neuroendocrine Carcinoma Market: Targeted Therapy Projected to be the Fastest Growing Segment by Treatment Type Through 2027:...
Genitourinary Pathology Society - Case of the Week 30
Symptoms of neuroendocrine carcinoma of the cervix? - DamnCancer
Oncology Reports
Comparison of clinical outcome in pulmonary neuroendocrine carcinoma (NEC) and extra-pulmonary NEC | OncologyPRO
Characterization of Gene Expression During Adenosine 3:5-Cyclic Monophosphate Induced Neuroendocrine Differentiation in Human...
Gold Drugstore: Teva generic viagra prime quality!
Plus it
Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results ...
Neuroendocrine Carcinoma | Cancer Survivors Network
Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine carcinoma - ecancer
Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ | Journal of Clinical Pathology
Challenges in the diagnosis and management of well-differentiated neuroendocrine tumors of the lung (typical and atypical...
Pulmonary Carcinoid Tumors: The Need for Tailored Assessment | Cancer Network | The Oncology Journal
Final Diagnosis -- Case 849
A giant non-functioning pancreatic neuroendocrine carcinoma founded as an incidentaloma successfully treated with...
ICD-10-CM Code C44.42 - Squamous cell carcinoma of skin of scalp and neck
ICD-10-CM Code C44.32 - Squamous cell carcinoma of skin of other and unspecified parts of face
Neuroendocrine cancers of the colon and rectum: results of a ten-year experience
Best Neuroendocrine Cancer Doctor in Gurgaon, Neuroendocrine Cancer Doctors Page - 7 | Credihealth
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra...
P172 Training nurses in sampling and acquisition of specimen during EBUS guided transbronchial needle aspiration | Thorax
APESP - Associação dos Patologistas do Estado de São Paulo
Pharmacodynamic evaluations of paired tumor biopsies in advanced neuroendocrine carcinomas (NECs) treated with the mTOR...
Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis | World Journal of Surgical Oncology | Full...
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer - Full Text View - ClinicalTrials.gov
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer - Full Text View - ClinicalTrials.gov
A simplified prognostic system for resected pancreatic neuroendocrine neoplasms…
Rare Cancer News & Clinical Trials » Trial - Neuroendocrine Cancers » TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic...
Most recent papers with the keyword Rounds | Read by QxMD
Neuroendocrine cancer throat - Recherche de papillomavirus chez l homme
Rare Cancer News & Clinical Trials » Trial - Neuroendocrine Cancers » Study to Evaluate the Use of Resources and the Costs...
Liver directed therapy Archives - Ronny Allan - Living with Neuroendocrine Cancer
Neuroendocrine cancer survivors - programul-tv.ro
Institute of Cancer Research Repository - Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated...
Pathology of Large Cell Carcinoma of Lung - Dr Sampurna Roy MD
antibodies fading - FluMap - Influenza A Virus host Interaction NatTrol Control
Thymus
Duodenal
International Classification of Diseases for Oncology (ICD-O) Archives - Ronny Allan - Living with Neuroendocrine Cancer
Follow-up after treatment for neuroendocrine tumours (NETs) - Canadian Cancer Society
New outlook for neuroendocrine cancer | Cancer Network | The Oncology Journal
Differential Diagnosis in Neuroendocrine Neoplasms of the Larynx
Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia -...
My Journey with NeuroEndocrine Cancer | Teresa Hirst
Fișier:Papilloma Virus (HPV) zanzi.ro, Hpv viren gebarmutterhals Neuroendocrine cancer fundraiser
Apoptosis and Its Modulation by Drugs by R. Cameron, G. Feuer (auth.), Professor Ross G. Cameron - CROUSTIGLAM.COM Library
Xueping Fang
Nunez, Rodolfo
Enolase 2
NSE is produced by small-cell carcinomas, which are neuroendocrine in origin. NSE is therefore a useful tumor marker for ... "Molecular characterization of prostatic small-cell neuroendocrine carcinoma". Prostate. 55 (1): 55-64. doi:10.1002/pros.10217. ... 1985). "Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues ... Detection of NSE with antibodies can be used to identify neuronal cells and cells with neuroendocrine differentiation. ...
Endometrioid tumor
ISBN 978-0-7216-0187-8. Mulvany NJ, Allen DG (January 2008). "Combined large cell neuroendocrine and endometrioid carcinoma of ... Endometrioid carcinoma can also arise in the endometrium. Grades 1 and 2 are considered "type 1" endometrial cancer, while ... Carcinoma,+Endometrioid at the US National Library of Medicine Medical Subject Headings (MeSH) "ACS :: What Is Endometrial ... Endometrioid tumors are a class of tumor characterized by a resemblance to endometrium/ endometrial carcinoma, and over a third ...
Goblet cell carcinoid
... is a rare biphasic gastrointestinal tract tumour that consists of a neuroendocrine component and a conventional carcinoma, ... Neuroendocrine tumours van Eeden S, Offerhaus GJ, Hart AA, et al. (December 2007). "Goblet cell carcinoid of the appendix: a ... They have a characteristic biphasic appearance which includes (1) goblet cell-like cells, and (2) neuroendocrine-type nuclear ... specific type of carcinoma". Histopathology. 51 (6): 763-73. doi:10.1111/j.1365-2559.2007.02883.x. PMID 18042066.. ...
Gangliocytic paraganglioma
The microscopic differential diagnosis includes poorly differentiated carcinoma, neuroendocrine tumour and paraganglioma. GPs ... neuroendocrine-like), and (3) spindle cells (schwannoma-like). ...
GPR112
... gene expression has been identified as a marker for neuroendocrine carcinoma cells. GRCh38: Ensembl release 89: ... "Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas". Modern Pathology. 22 (2): 261-72. doi ...
Health effects of tobacco
Small Cell Lung Carcinoma (SCLC) is the most closely associated with almost 100% of cases occurring in smokers.[56] This form ... SCLC may originate from neuroendocrine cells located in the bronchus called Feyrter cells.[57] ... Lipworth L, Tarone RE, McLaughlin JK (December 2006). "The epidemiology of renal cell carcinoma". The Journal of Urology. 176 ( ... "Smoking and carcinoma of the lung. Preliminary report", by Richard Doll and Austin Hill,[235][13] and the 1950 Wynder and ...
Transcatheter arterial chemoembolization
... plays a palliative role in patients with metastatic colon carcinoma. There is a ... Other treated malignancies include neuroendocrine tumors, ocular melanoma, cholangiocarcinoma, and sarcoma. ... conceptualized carcinogenesis of hepatocellular carcinoma (HCC) as a multistep process involving parenchymal arterialization, ... for the treatment of single hepatocellular carcinoma". World J Gastroenterol. 13 (21): 2952-5. doi:10.3748/wjg.v13.i21.2952. ...
Owen Witte
"N-Myc drives small cell neuroendocrine carcinoma initiated from human prostate epithelial cells". Cancer Cell. 29 (4): 536-547 ... leads to the development of aggressive neuroendocrine prostate cancer tumors. Witte earned his B.S. degree in microbiology from ...
Urachal cancer
Other rare types include urothelial carcinoma, squamous cell carcinoma, neuroendocrine carcinoma and sarcoma. Urachal cancer ... "Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition". ... Herr, Harry W.; Bochner, Bernard H.; Sharp, David; Dalbagni, Guido; Reuter, Victor E. (July 2007). "Urachal Carcinoma: ... In addition, other diagnostic systems also for urachal carcinomas that are not adenocarcinomas have been proposed. ...
Alphonse Mouzon
On September 7, 2016, Mouzon was diagnosed with neuroendocrine carcinoma, a rare form of cancer. His son, Jean-Pierre Mouzon, ...
Neuroectodermal neoplasm
... neuroendocrine carcinomas. These show predominantly epithelial differentiation. They include pituitary adenoma and carcinoid ... "Neuroectodermal Neoplasms of the Head and Neck with Emphasis on Neuroendocrine Carcinomas". Modern Pathology. 15 (3): 264-278. ...
Melanoma
Mills SE (March 2002). "Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas". Modern ... Sunscreen also protects against squamous cell carcinoma, another skin cancer. Concerns have been raised that sunscreen might ...
Lung cancer
Small-cell lung carcinoma may originate from these cell lines or neuroendocrine cells, and it may express CD44. Metastasis of ... such as adenosquamous carcinoma. Rare subtypes include carcinoid tumors, bronchial gland carcinomas, and sarcomatoid carcinomas ... Lung cancers are carcinomas - malignancies that arise from epithelial cells. Lung carcinomas are categorized by the size and ... The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are ...
Atypical pulmonary carcinoid tumour
... "moderately differentiated neuroendocrine carcinoma". It is a more aggressive than typical carcinoid tumors: nodal metastases in ...
Deaths in December 2016
... neuroendocrine carcinoma. John Nike, 81, English businessman. Miriam Pirazzini, 98, Italian opera singer. Núria Pompeia, 85, ... William Christopher, 84, American actor (M*A*S*H, Gomer Pyle, U.S.M.C., The Smurfs), small-cell carcinoma. Henning ...
SIR-Spheres
These are mostly patients with hepatocellular carcinoma (HCC), metastatic colorectal cancer (mCRC), or metastatic ... neuroendocrine tumours (mNET). Therapy goals are local disease control, downstaging to resection, bridging to transplantation, ...
Immunocontraception
"Selective expression of trophoblastic hormones by lung carcinoma: neuroendocrine tumors exclusively produce human chorionic ... cervical carcinoma, gastric carcinoma, squamous-cell carcinoma of the oral cavity and oropharynx, lung carcinoma, and ... progressive vulvar carcinoma, carcinoma of the bladder, pancreatic adenocarcinoma, ... Zhang, W; H Yang; S Han (1998). "The effect of ectopic HCG on microvessel density in gastric carcinoma". Chin J Oncol. 20: 351- ...
Rak żołądka człowieka, wolna encyklopedia
high grade neuroendocrine carcinoma, ICD-O 8246/3) *z dużych komórek (ang. large cell neuroendocrine carcinoma, ICD-O 8013/3) ... mixed adeno-neuroendocrine carcinoma, mixed adenocarcinoma-carcinoid, ICD-O 8244/3). *rak z komórek okładzinowych (ang. ... squamous cell carcinoma, ICD-O 8070/3). *rak z limfoidnym podścieliskiem (rdzeniasty) (ang. carcinoma with lymphoid stroma ( ... signet ring cell carcinoma and other variants; poorly cohesive carcinoma, ICD-O 8490/3) ...
DLK1
... a Putative Mammalian Homeotic Gene Differentially Expressed in Small Cell Lung Carcinoma and Neuroendocrine Tumor Cell Line". ... Helman, L. J. (1987). "Molecular Markers of Neuroendocrine Development and Evidence of Environmental Regulation". Proceedings ... A Novel Circulating Human Epidermal-Growth-Factor-Like Protein Expressed in Neuroendocrine Tumors and its Relation to the Gene ...
Pancreatic cancer
Other exocrine cancers include adenosquamous carcinomas, signet ring cell carcinomas, hepatoid carcinomas, colloid carcinomas, ... Neuroendocrine[edit]. Main article: Pancreatic neuroendocrine tumor. The small minority of tumors that arise elsewhere in the ... Pancreatic Neuroendocrine Tumors *^ Tejani MA, Saif MW (2014). "Pancreatic neuroendocrine tumors: Does chemotherapy work?". ... Main articles: Neuroendocrine tumor and Pancreatic neuroendocrine tumor. Treatment of PanNETs, including the less common ...
Merkel cell polyomavirus
... polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas". ... cutaneous squamous cell carcinoma, Bowen's disease, basal cell skin carcinoma, extrapulmonary small cell carcinoma, and EGFR ... Merkel cell carcinoma is a highly aggressive type of skin cancer that was first described by Cyril Toker in 1972 as "trabecular ... Merkel cell carcinoma is mainly seen in older individuals. It is known to occur at increased frequency in people with ...
Surface epithelial-stromal tumor
15-30% of endometrioid carcinomas occur in individuals with carcinoma of the endometrium, and these patients have a better ... Kaphan AA, Castro CM (2014-01-01). MPH rG, FRCPATH RH, MD JO, MD MJ (eds.). Small Cell and Neuroendocrine Cancers of the Ovary ... Bakhru A, Liu JR, Lagstein A (2012). "A case of small cell carcinoma of the ovary hypercalcemic variant in a teenager". ... Endometrioid tumors account for approximately 20% of all ovarian cancers and are mostly malignant (endometroid carcinomas). ...
SOX2
In squamous cell carcinoma, gene amplifications frequently target the 3q26.3 region. The gene for Sox2 lies within this region ... Overexpression causes an increase in neuroendocrine, gastric/intestinal and basal cells. Under normal conditions, Sox2 is ... Sox2 is a key upregulated factor in lung squamous cell carcinoma, directing many genes involved in tumor progression. Sox2 ... However, its overexpression gives rise to extensive epithelial hyperplasia and eventually carcinoma in both developing and ...
Seminal vesicles
Even rarer neoplasms include sarcoma, squamous cell carcinoma, yolk sac tumor, neuroendocrine carcinoma, paraganglioma, ...
David Carr (journalist)
... metastatic small cell neuroendocrine carcinoma). He was transported to Mount Sinai Roosevelt Hospital, where he later died. The ...
Parafollicular cell
... s, also called C cells, are neuroendocrine cells in the thyroid. The primary function of these cells is to ... When parafollicular cells become cancerous, they lead to medullary carcinoma of the thyroid. List of human cell types derived ... Parafollicular cells are also known to secrete in smaller quantities several neuroendocrine peptides such as serotonin, ...
Salt-and-pepper chromatin
... is typically seen in endocrine tumours such as medullary thyroid carcinoma, neuroendocrine tumours ...
Transdifferentiation
No standard of care exists for these patients, and those diagnosed with treatment induced neruoendocrine carcinoma are ... Davies, AH; Beltran, H; Amina Zoubeidi (May 2018). "Cellular plasticity and the neuroendocrine phenotype in prostate cancer". ... Aggarwal, R; Zhang, T; Small, EJ; Armstrong, AJ (May 2014). "Neuroendocrine prostate cancer: subtypes, biology, and clinical ... In prostate cancer, treatment with androgen receptor targeted therapies induces neuroendocrine transdifferentiation in a subset ...
Cancer of unknown primary origin
... or squamous cell carcinomas (5%). Rarely, CUP may appear as neuroendocrine tumors, or mixed tumors, such as sarcomatoid, ... A PET CT scan should be done for squamous cell carcinoma involving lymph nodes of the neck region. For other types of cancer of ... Krishnatreya M, Sharma JD, Kataki AC, Kalita M (2014). "Survival in carcinoma of unknown primary to neck nodes treated with ... Varadhachary, Gauri R. (2007). "Carcinoma of Unknown Primary Origin". Gastrointestinal Cancer Research : GCR. 1 (6): 229-235. ...
National Institute of Arthritis and Musculoskeletal and Skin Diseases
One area of focus is skin sensory neuroendocrine cells, Merkel cells, and the pathogenesis and treatment of Merkel cell ... carcinoma (MCC). An important area of research for the Branch includes investigation of the skin microbiome in health and ...
Category:Cancer - Simple English Wikipedia, the free encyclopedia
Nasopharyngeal carcinoma. *Neuroblastoma. *Neuroendocrine tumor. *Non-Hodgkin lymphoma. O. *Oncogene. *Oncology. *Oral cancer ...
Kallmann syndrome
"Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions". The Journal of Clinical Investigation ... PTCH1 (Nevoid basal-cell carcinoma syndrome). *BMPR1A (BMPR1A juvenile polyposis syndrome). *IL2RG (X-linked severe combined ... "Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system" ...
CD30
It is expressed in embryonal carcinoma but not in seminoma and is thus a useful marker in distinguishing between these germ ...
Radiation therapy
2005). "Cervix carcinoma". In Gerbaulet A, Pötter R, Mazeron J, Limbergen EV. The GEC ESTRO handbook of brachytherapy. Belgium ... and of hormone-bound lutetium-177 and yttrium-90 to treat neuroendocrine tumors (peptide receptor radionuclide therapy). ... In the treatment of nasopharyngeal, oropharyngeal and hypopharyngeal carcinomas VMAT provides equivalent or better OAR ...
Pleomorphism (cytology)
Certain benign cell types may have pleomorphism, e.g. neuroendocrine cells, Arias-Stella reaction. ... Giant cell carcinoma of the lung. *Nuclear atypia. This article related to pathology is a stub. You can help Wikipedia by ...
David Carr (journalist)
... metastatic small cell neuroendocrine carcinoma). He was transported to St. Luke's-Roosevelt Hospital, where he later died.[24][ ...
Carcinoid
The WHO now divides these growths into neuroendocrine tumors and neuroendocrine cancers. Neuroendocrine tumors are growths that ... The term 'crypt cell carcinoma' has been used for them, and though perhaps more accurate than considering them carcinoids, has ... Neuroendocrine cancers are abnormal growths of neuroendocrine cells which can spread to other parts of the body. ... type of neuroendocrine tumor originating in the cells of the neuroendocrine system. In some cases, metastasis may occur. ...
Paraneoplastic syndrome
The purpose of this clinical case demonstrates the aggressive nature of the neuroendocrine small cell carcinoma with rapid ... a case report of Neuroendocrine Small Cell Carcinoma of the Endometrium presenting as Paraneoplastic Cushing's Syndrome". Facts ... In the case of paraneoplastic Cushing's syndrome arising from a small cel carcinoma of the endometrium, paraneoplastic syndrome ... "Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies", Lancet, 341 (8836): 21-22, doi: ...
神經母細胞瘤 - 维基百科,自由的百科
胰腺神經內分泌腫瘤(英语:Pancreatic neuroendocrine tumor)(PanNETs) ... 鱗狀細胞癌(英语:Squamous-cell thyroid carcinoma). *良性 *甲狀腺腺瘤(
Secondary hypertension
Neuroendocrine tumors are also a well known cause of secondary hypertension. Pheochromocytoma[35] (most often located in the ... and renal cell carcinoma, all of which may produce renin.[12] ...
Carcinoma
In some types of carcinomas, Stage 0 carcinoma has been used to describe carcinoma in situ, and occult carcinomas detectable ... Some carcinomas are named for their or the putative cell of origin, (e.g.hepatocellular carcinoma, renal cell carcinoma). ... Carcinoma In situ[edit]. The term carcinoma in situ (or CIS) is a term for cells that are significantly abnormal but not cancer ... and sarcomatoid carcinoma (mixtures of spindle and giant cell carcinoma). Pleomorphic carcinoma contains spindle cell and/or ...
Tüümus - Vikipeedia
César A Moran M.D. ja Saul Suster M.D., Primary Neuroendocrine Carcinoma (Thymic Carcinoid) of the Thymus with Prominent ... VICTOR C. JACOBSON, M.D., PRIMARY CARCINOMA OF THE THYMUS, juuni 1923, 31. väljaanne, nr 6, Arch Intern Med (Chic). 1923;31(6): ... Savino W, Dardenne M., Neuroendocrine control of thymus physiology. Lühikokkuvõte, Endocr Rev. august 2000;21(4):412-43., ( ... Savino W, Dardenne M., Neuroendocrine control of thymus physiology. Lühikokkuvõte, Endocr Rev. august 2000;21(4):412-43., 2000 ...
Targeted therapy of lung cancer
See also: Combined small-cell lung carcinoma. The term "combined small-cell lung carcinoma" (c-SCLC) refers to a multiphasic ... "Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors". Archives of ... Because of the ubiquity of lung carcinomas, however, the term "lung cancer" generally refers to carcinomas in everyday clinical ... About 2% of all lung cancers are non-carcinoma (mainly sarcoma, tumors of hematopoietic origin, or germ cell tumors.[5] These ...
Ribociclib
... endometrial carcinoma[14] and neuroendocrine tumors of the foregut.[15] ... Clinical trial number NCT02420691 for "LEE011 in Neuroendocrine Tumors of Foregut Origin" at ClinicalTrials.gov ... in Patients With Advanced or Recurrent Endometrial Carcinoma" at ClinicalTrials.gov ...
Somatostatinoma
Ellison TA, Edil BH (2012). "The current management of pancreatic neuroendocrine tumors". Adv Surg (46): 283-296. PMID 22873046 ... Papilloma/carcinoma. (8010-8139). *Small cell carcinoma. *Combined small cell carcinoma. *Verrucous carcinoma ...
Hepatocellular adenoma
Adrenocortical adenoma/Adrenocortical carcinoma. *Hurthle cell. Other/multiple. *Neuroendocrine tumor *Carcinoid. *Adenoid ...
Pancreatic neuroendocrine tumor
... termed neuroendocrine cancer (NEC) in the WHO scheme, is synonymous with "islet cell carcinoma". ... PanNETs are a type of neuroendocrine tumor, representing about one third of gastroenteropancreatic neuroendocrine tumors (GEP- ... Pancreatic neuroendocrine tumors (PanNETs, PETs, or PNETs), often referred to as "islet cell tumors",[1][2] or "pancreatic ... a b Everolimus Approved for Pancreatic Neuroendocrine Tumors. The ASCO Post. May 15, 2011, Volume 2, Issue 8 "Archived copy". ...
Cathepsin D
The NCLs present with progressive loss of visual function and neurodevelopmental decline, seizure, myoclonic jerks and premature death. The CTSD gene is one of the identified eight genes the deficiency of which is responsible for NCLs.[10] It has been reported that a homozygous single nucleotide duplication in exon 6 could alter the reading frame and causes a premature stop codon at position 255. Over-expression of cathepsin D stimulates tumorigenicity and metastasis as well as initiation of tumor apoptosis. This protease has been regarded an independent marker of poor prognosis in breast cancer being correlated with the incidence of clinical metastasis.[21][22] Knock-out of CTSD gene would cause intestinal necrosis and hemorrhage and increase apoptosis in thymus, indicating that cathepsin D is required in certain epithelial cells for tissue remodeling and renewal.[9] It is also reported that there might be a strong effect for CTSD genotype on Alzheimer disease risk in male.[23] Cathepsin D ...
Cancer syndrome
... renal cell carcinoma of chromophobe, hybrid oncocytic, or oncocytoma histology; sebaceous carcinoma; and sex cord tumors with ... pancreatic neuroendocrine tumours, pancreatic cysts, endolymphatic sac tumors and epididymal papillary cystadenomas. VHL ... but also increases the risk of fallopian tube carcinoma and papillary serous carcinoma of the peritoneum. In men the risk of ... Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is an autosomal dominant cancer syndrome in which ...
Chicken
... reproduction is controlled by a neuroendocrine system, the Gonadotropin-Releasing Hormone-I neurons in the hypothalamus. ... Squamous cell carcinoma cancer Tibial dyschondroplasia speed growing Toxoplasmosis Toxoplasma gondii Ulcerative enteritis ...
Ceruminous adenocarcinoma
... ceruminous adenoid cystic carcinoma (ACC),[1][2] and ceruminous mucoepidermoid carcinoma. ... or a neuroendocrine adenoma of the middle ear (middle ear adenoma).[9] ... Ceruminous mucoepidermoid carcinoma. All of the tumors are infiltrative into the soft tissue, benign ceruminous glands, and/or ... The specific features of each tumor type can help with the separation into adenoid cystic carcinoma or mucoepidermoid types.[3] ...
Linitis plastica
Microscopic appearance is signet ring cell carcinoma, which is tumor cells with mucin droplet that displaces the nucleus to one ... particularly breast and lung carcinoma.[1] It is not associated with H. pylori infection or chronic gastritis. The risk factors ... Adrenocortical adenoma/Adrenocortical carcinoma. *Hurthle cell. Other/multiple. *Neuroendocrine tumor *Carcinoid. *Adenoid ...
Succinate dehydrogenase
Loss-of-function mutations result in paraganglioma, a neuroendocrine tumour.[13] History[edit]. The recent studies which ... succinate dehydrogenase deficient renal carcinoma and succinate dehydrogenase deficient gastrointestinal stromal tumor (GIST).[ ...
Thyroid
The neuroendocrine parafollicular cells, also known as C cells, responsible for the production of calcitonin, are derived from ... Malignant nodules, which only occur in about 5% of nodules, include follicular, papillary, medullary carcinomas and metastases ... Malignant thyroid cancers are most often carcinomas, although cancer can occur in any tissue that the thyroid consists of, ... "The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review". The American Journal of ...
Typical pulmonary carcinoid tumour
Non-small-cell lung carcinoma. *Squamous-cell carcinoma. *Adenocarcinoma (Mucinous cystadenocarcinoma). *Large-cell lung ...
胰臟癌 - 維基百科,自由的百科全書
... adenosquamous carcinoma)、印戒細胞癌、肝樣細胞癌(英語:hepatoid carcinoma)、膠狀癌、未分化腺癌和具有蝕骨細胞(英語:osteoclast)樣巨大細胞(英語:giant cell)的未分化腺癌。固狀偽乳頭狀腫瘤( ... Pancreatic Neuroendocrine Tumors. *^ Tejani, Mohamedtaki Abdulaziz; Saif, Muhammad Wasif. Pancreatic neuroendocrine tumors: ... 胰臟內的腫瘤也可能來自身體的其他地方,但這種
Update on Neuroendocrine Carcinomas of the Larynx
This review aims to clarify the nature and classification of laryngeal neuroendocrine neoplasms, while providing a practical ... Moderately Differentiated Neuroendocrine Carcinoma of the Larynx. *Poorly Differentiated Neuroendocrine Carcinoma of the Larynx ... Moderately Differentiated Neuroendocrine Carcinoma of the Larynx. *Poorly Differentiated Neuroendocrine Carcinoma of the Larynx ... Classification of Neuroendocrine Carcinomas of the Larynx: Historical Evolution. *Well-differentiated Neuroendocrine Carcinoma ...
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? | SpringerLink
Neuroendocrine breast carcinomas are rare but may represent either metastatic or primary lesions. So far, clinical and ... Neuroendocrine breast carcinomas are rare but may represent either metastatic or primary lesions. So far, clinical and ... Sapino A, Righi L, Cassoni P et al (2001) Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of ... Lopez-Bonet E, Alonso-Ruano M, Barraza G et al (2008) Solid neuroendocrine breast carcinomas: incidence, clinico-pathological ...
Laryngeal Neuroendocrine Carcinomas: A Retrospective Study of 14 Cases
... small cell neuroendocrine carcinoma, and large cell neuroendocrine carcinoma. The neural category is mainly referred to as ... and small cell neuroendocrine carcinoma. Laryngeal large cell neuroendocrine carcinoma was classified together with atypical ... and 7 as small cell neuroendocrine carcinoma. One of the small cell neuroendocrine carcinoma cases was demonstrated to couple ... followed by the small cell neuroendocrine carcinoma, typical carcinoid, and the large cell neuroendocrine carcinoma [5]. The ...
Laryngeal Neuroendocrine Carcinomas: A Retrospective Study of 14 Cases
Large-cell neuroendocrine carcinoma of the lung
... Cancer Control. 2006 Oct;13(4):270-5. doi: 10.1177/107327480601300404. ... Background: Large-cell neuroendocrine carcinoma (LCNEC) of the lung displays morphologic and immunohistochemical ... characteristics common to neuroendocrine tumors and morphologic features of large-cell carcinomas. Because surgical resection ...
Neuroendocrine carcinoma of the cervix - Wikipedia
Small-cell carcinoma (SCC) of the cervix is an exceptional member of the neuroendocrine group of cervical carcinomas that is ... Neuroendocrine carcinoma of the cervix is best defined separately:Neuroendocrine: Of, relating to, or involving the interaction ... carcinoma_of_the_cervix/intro.htm Neuroendocrine system "MRI of Small Cell Carcinoma of the Uterine Cervix with Pathologic ... Neuroendocrine carcinoma affects many different parts of the body. In the cervix, it is a rare, but very aggressive form of ...
Chemotherapy Effective For Patients With Resected SCLC Or Large-Cell Neuroendocrine Carcinoma - Redorbit
Whereas large-cell neuroendocrine carcinoma (LCNEC) is a subgroup of large-cell carcinoma, that has characteristics similar to ... Chemotherapy Effective For Patients With Resected SCLC Or Large-Cell Neuroendocrine Carcinoma. by editor ... concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were ...
Neuroendocrine Carcinoma Patient Inspires Fellow Patients, Staff | MD
Anderson Cancer Center
Neuroendocrine carcinoma of the jugular foramen. - Free Online Library
Neuroendocrine carcinoma of the jugular foramen.(ORIGINAL ARTICLE, Clinical report) by Ear, Nose and Throat Journal; Health, ... general Cancer Care and treatment Chemotherapy Diagnosis Methods Research Cancer metastasis Cancer treatment Carcinoma Medical ... research Medicine, Experimental Metastasis Neuroendocrine tumors Risk factors Radiotherapy ... carcinoma+of+the+jugular+foramen.-a0176368943. *APA style: Neuroendocrine carcinoma of the jugular foramen.. (n.d.) >The Free ...
Clinicopathologic features of primary renal neuroendocrine carcinoma]
... diagnostic features and prognosis of primary renal neuroendocrine carcinoma (NEC). Methods: The clinicopathologic data of eight ... Clinicopathologic features of primary renal neuroendocrine carcinoma] November 21, 2018 Objective: To investigate the ... The Ki-67 proliferation index was≤3% in the carcinoids; ≥50% in the small cell carcinoma and large cell carcinoma; and 5% and 8 ... Three patients (two with small cell carcinoma and one with large cell carcinoma) died of extensive metastases at 3 months, 4 ...
Primary neuroendocrine carcinoma of inguinal lymph node
Inguinal lymph nodes as the primary tumor site for neuroendocrine carcinoma represent a very unusual location, and have only ... Ninety-seven percent of neuroendocrine carcinomas are located in the gastrointestinal tract or in the bronchopulmonary tree. ... Primary neuroendocrine carcinoma of inguinal lymph node Horm Res. 2005;64(1):16-9. doi: 10.1159/000087191. Epub 2005 Jul 25. ... Inguinal lymph nodes as the primary tumor site for neuroendocrine carcinoma represent a very unusual location, and have only ...
Large Cell & Small Cell Gastrointestinal Neuroendocrine Carcinoma | Memorial Sloan Kettering Cancer Center
... but Memorial Sloan Kettering experts have experience treating both large cell neuroendocrine carcinoma and small cell carcinoma ... The following tests may be performed to confirm a diagnosis of large cell neuroendocrine carcinoma or small cell carcinoma. ... Small Cell Carcinoma. This is another aggressive type of neuroendocrine tumor that accounts for between 0.1 percent to 1 ... Large Cell Neuroendocrine Carcinoma. This fast-growing type of cancer represents less than 1 percent of all gastrointestinal ...
Neuroendocrine Carcinoma | Cancer Survivors Network
I had a tumor removed from my liver and it was diagnosed as NEC. They arent sure if its the primary but I had tumor markers done recently and all my levels were normal. Have any of you had markers done and levels were normal but more tumors were found? Im asking because less than 1% of NEC tumors originate in the liver and that is where mine was, so Im worried there might be something somewhere else that isnt excreting any horomones. ...
Circulating neuroendocrine markers in patients with prostate carcinoma.
Circulating neuroendocrine markers were measured in patients with prostate carcinoma (PC), prostatic intraepithelial neoplasia ... BACKGROUND: Circulating neuroendocrine markers were measured in patients with prostate carcinoma (PC), prostatic ... Carcinoma / blood*, mortality. Chromogranin A. Chromogranins / blood*. Cohort Studies. Humans. Male. Middle Aged. ... Previous Document: Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor .... ...
Large cell neuroendocrine carcinoma of the lung - Wikipedia
Large cell neuroendocrine carcinoma of the lung (LCNEC) is a highly malignant neoplasm arising from transformed epithelial ... "combined large cell neuroendocrine carcinoma" (c-LCNEC). Travis, William D; Brambilla, Elisabeth; Muller-Hermelink, H Konrad; ... It is currently considered to be a subtype of large cell lung carcinoma. LCNEC is often generically grouped among the non-small ... cell lung carcinomas. The World Health Organization classification of lung tumors recognizes a variant of LCNEC, namely " ...
Is human papillomavirus involved in laryngeal neuroendocrine carcinoma? - Research database - University of Groningen
Is human papillomavirus involved in laryngeal neuroendocrine carcinoma?. Halmos, G. B., van der Laan, T. P., van Hemel, B. M., ... Is human papillomavirus involved in laryngeal neuroendocrine carcinoma? / Halmos, Gyorgy B; van der Laan, Tom P; van Hemel, ... High-risk HPV was detected in two cases; an atypical carcinoid was positive for HPV16 and a large-cell neuroendocrine carcinoma ... High-risk HPV was detected in two cases; an atypical carcinoid was positive for HPV16 and a large-cell neuroendocrine carcinoma ...
neuroendocrine carcinoma | West Indian Medical Journal
Large cell neuroendocrine carcinoma primarily in the pericar... : Chinese Medical Journal
... large cell neuroendocrine carcinoma and carcinoid tumors. Based on the differentiation grade, neuroendocrine tumors are ... Large cell neuroendocrine carcinoma primarily in the pericardium. a case report and literature review. Yin, Yue1; Zhang, Yun1; ... Large cell neuroendocrine carcinoma of the endometrium: a case report and literature review. Taiwan J Obstet Gynecol 2018; 57: ... Large cell neuroendocrine carcinoma primarily in the pericardium: A case report and literature review. Chin Med J 2019;133:106- ...
Chemotherapy effective for patients with resected SCLC or large-cell neuroendocrine carcinoma
Whereas large-cell neuroendocrine carcinoma (LCNEC) is a subgroup of large-cell carcinoma, that has characteristics similar to ... Chemotherapy effective for patients with resected SCLC or large-cell neuroendocrine carcinoma. 18.06.2012 ... Association »IASLC »SCLC »Small-cell lung cancer »cell lung cancer »chemotherapy »lung cancer »neuroendocrine tumors » ... concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were ...
Primary neuroendocrine carcinoma of the breast: a 5-year experiences.
... we aimed to evaluate the data of patients diagnosed with primary breast neuroendocrine carcinoma. METHODS: Patients with more ... than 50% neuroendocrine differentiation identified in the histopathological examination between January 2010 and January 2015 ... More News: Brain , Breast Cancer , Breast Carcinoma , Cancer , Cancer & Oncology , Carcinoma , Chemotherapy , Ductal Carcinoma ... Primary neuroendocrine carcinoma of the breast: a 5-year experiences.. In this study, we aimed to evaluate the data of patients ...
A case of small intestinal neuroendocrine carcinoma diagnosed using double-balloon endoscopy with long-term survival |...
... including neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs), are rare epithelial tumors with a predominant ... Neuroendocrine neoplasms, including neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs), are rare epithelial ... Neuroendocrine carcinoma Small intestine Double balloon endosopy This is a preview of subscription content, log in to check ... A case of small intestinal neuroendocrine carcinoma diagnosed using double-balloon endoscopy with long-term survival. ...
Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma - Full Text View - ClinicalTrials.gov
Neuroendocrine Tumors. Carcinoma, Neuroendocrine. Neuroectodermal Tumors. Neoplasms, Germ Cell and Embryonal. Neoplasms by ... Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma (Pembro NEC). The safety and scientific ... Histologically confirmed, metastatic or unresectable neuroendocrine carcinoma of non-pulmonary origin, high grade as indicated ... Exceptions include basal cell carcinoma of the skin or squamous cell carcinoma of the skin that has undergone potentially ...
Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma
This phase II trial is studying how well CCI-779 works in treating patients with progressive metastatic neuroendocrine tumors. ... A Phase II Study of CCI-779 in Metastatic Neuroendocrine Carcinomas. Trial Phase:. Phase 2. Minimum Age:. 18 Years. Maximum Age ... A Phase II Study of CCI-779 in Metastatic Neuroendocrine Carcinomas. OBJECTIVES:. I. To assess the objective tumor response ... time, 1-year survival rate and toxicity in patients with metastatic neuroendocrine. carcinomas given CCI-779. As of 19 July ...
BRAF Mutations May Be Driver of Colonic Neuroendocrine Carcinoma | Cancer Network
A study exploring the genetic underpinnings of the newly classified high-grade neuroendocrine carcinoma has found that it is a ... neuroendocrine tumor (NET) and high-grade neuroendocrine carcinoma (NEC). These classifications are based on mitosis and ... A study exploring the genetic underpinnings of the newly classified high-grade neuroendocrine carcinoma has found that it is a ... A study exploring the genetic underpinnings of the newly classified high-grade neuroendocrine carcinoma has found that it is a ...
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
Neuroendocrine carcinoma (NEC) arising from the esophagus (EsoNEC) is extreme rare, accounting for approximately 1% of ... cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet ... Carcinoma, Neuroendocrine. A group of carcinomas which share a characteristic morphology, often being composed of clusters and ... "Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.". Neuroendocrine ...
Prostate cancer: Neuroendocrine carcinoma | HealthEngine Blog
Neuroendocrine carcinoma of the prostate is a rare form of cancer which affects the hormone-producing cells of the prostate. ... If cancer arises in the neuroendocrine cells of the prostate, it is known as neuroendocrine carcinoma of the prostate. This is ... Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects ... What is Prostate Cancer (Neuroendocrine Carcinoma of the Prostate)?. The prostate is a gland found only in men. It surrounds ...
All Specialist in Neuroendocrine Carcinoma messages
Specialist in Neuroendocrine Carcinoma. by LelaLu on Sat Sep 09, 2017 07:28 PM ... My brother has very aggressive, widely metastasized neuroendocrine carcinoma. From what I understand, its treated very ... Specialist in Neuroendocrine Carcinoma. Specialist in Neuroendocrine Carcinoma. View all Other Cancers Discussions Post A New ...
Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas - No Study Results Posted -...
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Foreca... ( NEW YORK May 15 2012 /- Reportlinker....)
GlobalData has estimated that the global neuroendocrine carcinoma ther...,Neuroendocrine,Carcinoma,Therapeutics,-,Pipeline, ... www.reportlinker.com/p0606218/Neuroendocrine-Carcinoma-Therapeu...Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment ... the US 303.5 Neuroendocrine Carcinoma Therapeutics Market Size (2006-2011) -the UK 313.6 Neuroendocrine Carcinoma Therapeutics ... Global 273.3 Neuroendocrine Carcinoma Therapeutics Market Size (2006-2011) - the US 293.4 Neuroendocrine Carcinoma Therapeutics ...
PRIME PubMed | Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses: Radiologic Features in 14 Cases
Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses: Radiologic Features in 14 Cases. Download Prime PubMed App to iPhone ... Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses: Radiologic Features in 14 Cases. J Comput Assist Tomogr. 2020 Jul 6; ... Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses: Radiologic Features in 14 Cases. J Comput Assist Tomogr. 2020. ... "Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses: Radiologic Features in 14 Cases." Journal of Computer Assisted ...
TumorsTumorDifferentiationAbstractSquamousNeoplasmsLCNECMalignantTumoursCancersEndocrine carcinomaNeoplasmGastrointestinal tractDiagnosisEpithelialGlobal neuroendocrine carcinomaGastroenteropancreatic neuroendocrine carcinomaAggressiveChemotherapyAdenocarcinomaLaryngealBreast carcinomasTransitional cell carcMetastasesHepaticImmunohistochemistryLung carcinomaCervical Large Cell Neuroendocrine CarcinomaImmunohistochemicalCervixLargeTherapeuticsSynaptophysinModerately differentiated neuroendocrine carcinomaTypes of neuroendocrine carcinomasRenal cell carcCancerTumourPoor prognosisPoorly differentiated carcinomaAtypical carcinoidType of neuroendocrine carcinomaCases of neuroendocrine carcinomaMetastatic neuroendocrine
Tumors89
- Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? (springer.com)
- We addressed this study in order to evaluate the immunohistochemical expression of GCDFP-15 and mammaglobin in a subset of pure neuroendocrine breast carcinomas ( n = 9) and compared the expression profile with a cohort of non-mammary neuroendocrine tumors ( n = 99). (springer.com)
- In contrast, neuroendocrine tumors of the non-mammary cohort expressed neither GCDFP-15 nor mammaglobin. (springer.com)
- We conclude that mammaglobin and GCDFP-15 as markers of epithelial breast origin may work as a new and reliable diagnostic tool to distinguish primary endocrine tumors of the breast from a metastatic neuroendocrine disease. (springer.com)
- Sica G, Wagner P, Altorki N, Port J et al (2008) Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. (springer.com)
- Laryngeal neuroendocrine carcinomas (LNECs) are rare but are the most common nonsquamous tumors of this organ, which can be divided into 2 broad categories based on their tissue of origin: epithelial and neural. (hindawi.com)
- Large-cell neuroendocrine carcinoma (LCNEC) of the lung displays morphologic and immunohistochemical characteristics common to neuroendocrine tumors and morphologic features of large-cell carcinomas. (nih.gov)
- Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone. (redorbit.com)
- The World Health Organization classification of lung tumors recognizes a variant of LCNEC, namely "combined large cell neuroendocrine carcinoma" (c-LCNEC). (wikipedia.org)
- The small cell renal cell carcinoma and large cell carcinoma are highly malignant renal tumors with poor prognosis and short survival. (urotoday.com)
- A few neuroendocrine tumors found in the gastrointestinal tract are made of fast-growing, poorly differentiated cancer cells, and respond to different treatments than those used for carcinoid tumors. (mskcc.org)
- This is another aggressive type of neuroendocrine tumor that accounts for between 0.1 percent to 1 percent of all gastrointestinal tumors. (mskcc.org)
- This type of imaging test is helpful in diagnosing more aggressive types of neuroendocrine tumors. (mskcc.org)
- There is no standard treatment protocol for primary breast neuroendocrine tumors. (medworm.com)
- Neuroendocrine neoplasms, including neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs), are rare epithelial tumors with a predominant neuroendocrine differentiation. (springer.com)
- Gastroenteropancreatic neuroendocrine tumors. (springer.com)
- Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study. (springer.com)
- Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. (springer.com)
- This is an open label, non-randomized phase 2 study to assess overall response rate (ORR), clinical benefit rate (CBR), overall survival (OS) and progression free survival (PFS) in patients with high grade neuroendocrine tumors treated with pembrolizumab 200mg Q 3 Weeks. (clinicaltrials.gov)
- The promising drugs to be launched include: Avastin (bevacizumab) and Lutathera ([177Lutetium]-DOTA0-Tyr3-Octreotate) for Gastrointestinal (GI) carcinoid and pancreatic Neuroendocrine Tumors (NETs), pasireotide (SOM 230), and Somatuline (lanreotide acetate) Autogel/Depot for GI carcinoids NETs. (bio-medicine.org)
- In a comprehensive genomic analysis of neuroendocrine carcinoma of gynecologic and breast tumors, investigators identified mutations in various pathways. (onclive.com)
- Mayor said that there were a significant number of p53 and Rb mutations, which are very common in neuroendocrine tumors from sites other than the gynecologic tract. (onclive.com)
- Some tumors as verrucous carcinomas, basal cell carcinomas, low-grade salivary gland cancers, rarely metastasize and extensive screening seems an unnecessary use of resources. (omicsonline.org)
- Neuroendocrine tumors commonly present as an over expression of the somatostatin-receptor-subtype 2 (SSR2) [ 1 , 8 , 9 ]. (omicsonline.org)
- To assess the prognostic significance of well differentiated versus poorly differentiated non-small cell gastroenteropancreatic neuroendocrine tumors in relationship to survival and response to treatment. (centerwatch.com)
- Neuroendocrine breast carcinoma (NBC) is an extremely rare type of cancer, constituting less than 0.1% of all breast tumors, without specific treatment options. (aacrjournals.org)
- Therapeutic biomarkers (IHC) that may guide chemotherapies (and used in other primary sites neuroendocrine tumors) included: high TOP2A (85%) for etoposide or doxorubicin, low TS (57%) for 5-fluorouracil and low ERCC1 (45%) for cisplatin. (aacrjournals.org)
- With recent success of somatostatin analogs for other neuroendocrine tumors, the overexpression of SSTR gene family in NBC is worthy of further investigation. (aacrjournals.org)
- Neuroendocrine carcinoma market is expected to witness lucrative growth over the forecast period due to increase in incidence of neuroendocrine tumors (NETs) around the globe. (grandviewresearch.com)
- Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital. (springermedizin.de)
- Oberg K. Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors. (springermedizin.de)
- One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. (springermedizin.de)
- This report presents 3 more such tumors, expanding the spectrum of amphicrine carcinomas in this organ. (ovid.com)
- Small intestine neuroendocrine tumors (NETs) comprise well-differentiated NET (benign carcinoid), well-differentiated neuroendocrine carcinoma (malignant carcinoid) and poorly differentiated neuroendocrine carcinoma (NEC). (enets.org)
- The finding that Ma2 is expressed in small intestine neuroendocrine primary tumors and their metastases made it interesting to screen whether antibodies against Ma2 are present in the serum of NET patients. (enets.org)
- Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system, originated from the diffuse endocrine system, represent a heterogeneous group of tumors. (enets.org)
- Treatment of poorly differentiated neuroendocrine tumors (NET) usually includes chemotherapeutic intervention. (enets.org)
- Poorly differentiated neuroendocrine tumors (PDEC) represent less than 10% of all neuroendocrine tumors but have a poor prognosis. (enets.org)
- Recent advances in specific treatment for neuroendocrine tumors (NETs) prompted us to reinvestigate the old phenomenon of neuroendocrine differentiation in carcinomas of the GI tract which has previously been shown to carry no prognostic significance. (enets.org)
- we don't see neuroendocrine tumors very often in the larynx. (justanswer.com)
- Pancreatic neuroendocrine tumors constitute about 2% of all gastrointestinal neoplasms. (diva-portal.org)
- Approximately half of the pancreatic neuroendocrine tumors are nonfunctional. (diva-portal.org)
- Due to lack of specific symptoms, most patients with nonfunctional pancreatic neuroendocrine tumors present with locally advanced or metastatic disease. (diva-portal.org)
- After surgery for operable colon carcinoma, the patient received chemotherapy and biological therapy for both tumors. (diva-portal.org)
- Therefore, positron emission tomography is a valuable promising option for the evaluation of gastroenteropancreatic neuroendocrine tumors and concomitant or metachronous malignancies. (diva-portal.org)
- According to a critical review of the literature performed by these authors, only four [ 2 - 5 ] of twelve previously reported cases showed convincing evidence od neuroendocrine differentiation and might therefore be regarded as pure carcinoid tumors of the urinary bladder. (biomedcentral.com)
- This issue of JNCCN-The Journal of the National Comprehensive Cancer Network contains the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) and other neuroendocrine lung tumors. (jnccn.org)
- In 2015, large cell neuroendocrine carcinoma (LCNEC) was removed from the large cell carcinoma group and classified with small cell lung carcinoma (SCLC) constituting two members of the high-grade neuroendocrine tumors (NETs) of the lung. (jcancer.org)
- Wang J, Ye L, Cai H, Jin M. Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study. (jcancer.org)
- Neuroendocrine tumors (NETs) of the gastrointestinal tract occur at an approximate incidence of 6.2 per 100,000 worldwide, and are the second most prevalent gastrointestinal tract tumor behind colorectal cancer (CRC). (jnccn.org)
- 2 Metastatic, high-grade, poorly differentiated neuroendocrine carcinomas (NECs) are typically aggressive tumors characterized by a Ki-67 level of >20% and a mitotic index of >20 mitoses per 10 high-powered field, and are generally treated with chemotherapy regimens used for small cell lung cancer. (jnccn.org)
- They comprise a broad family of tumors, Neuroendocrine Carcinoma (NEC) is a poorly differentiated and high-grade type (grade 3). (alliedacademies.org)
- Everolimus is an inhibitor of mammalian target of rapamycin (mTOR) which can use in metastatic neuroendocrine tumors [ 6 - 8 ]. (alliedacademies.org)
- Enteropancreatic neuroendocrine tumors spread first locally and to regional lymph nodes and from there generally to the liver. (rrnursingschool.biz)
- In addition to demonstrating the extent of enteropancreatic tumors, SRS can identify previously unsuspected disease in the chest or abdomen.63 Although SRS is useful in identifying otherwise occult neuroendocrine tumors in patients with MEN type I, and this can alter management substantially, it also has significant false-positive and false-negative rates, thus necessitating correlation with conventional imaging studies. (rrnursingschool.biz)
- Primary metastatic renal metastatic carcinoid tumor in a young male patient: a contribution to the differential diagnosis of neuroendocrine tumors]. (openrepository.com)
- Large cell neuroendocrine carcinoma is defined as a variant form of large cell carcinoma, and is classified in the wide spectrum of primary neuroendocrine tumors together with small cell carcinoma (SCC) and atypical carcinoid tumor. (biomedcentral.com)
- Malignant neuroendocrine pancreatic tumors are the most frequent cause of death in these patients. (biomedcentral.com)
- However, the extent and intervals of screening in patients with multiple endocrine neoplasia type 1 are controversial as neuroendocrine tumors are usually slow growing. (biomedcentral.com)
- Fast-growing neuroendocrine tumors are rare in patients with multiple endocrine neoplasia type 1. (biomedcentral.com)
- Specialized testing may indicate whether these tumors began in lymph cells, skin cells, neuroendocrine cells (which secrete hormones into the blood), or other specialized cells. (mskcc.org)
- For more information about neuroendocrine tumors, visit Gastrointestinal Neuroendocrine Tumors and Pulmonary Neuroendocrine Tumors . (mskcc.org)
- Background: Neuroendocrine carcinomas (NECs) of the stomach are poorly differentiated, high-grade endocrine tumors, including small cell and large cell carcinomas. (elsevier.com)
- Occasionally, like neuroendocrine tumors of the lung, small cell cancer of the cervix can present with paraneoplastic syndromes affecting the endocrine (hormonal) and/or nervous systems such as hypercalcemia (elevated blood calcium levels), neurologic disorders, Cushing's syndrome, and SIADH [11]. (damncancer.com)
- Neuroendocrine tumors of the rectum account for approximately 19% of gastrointestinal neuroendocrine tumors. (plexusmd.com)
- As the effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically the tumors are always malignant, and mostly detected with distant metastases. (biospraymakassar.com)
- A practical approach to pathologic diagnosis of laryngeal neuroendocrine tumors and discussion of clinical management is provided. (umn.edu)
- Neuroendocrine tumors are tumors that develop from the cells of the diffuse neuroendocrine system, such as the enterochromaffin (EC) cells. (encyclopedia.com)
- Neuroendocrine tumors therefore represent a large class of cancers that can occur wherever neuroendocrine cells are found throughout the body. (encyclopedia.com)
- They are sometimes called carcinoid tumors, but it would be more accurate to consider these tumors as a sub-category of the larger family of neuroendocrine tumors. (encyclopedia.com)
- Neuroendocrine tumors are most often found in the digestive system and the lung. (encyclopedia.com)
- Neuroendocrine pancreatic tumors are rather rare cancers with an incidence of 1-2 cases per 100, 000 people. (encyclopedia.com)
- Neuroendocrine tumors are also known as apudomas, or tumors that contain apud cells. (encyclopedia.com)
- Neuroendocrine tumors therefore have symptoms that vary with location. (encyclopedia.com)
- The majority of neuroendocrine tumors can give rise to metastases with time if they are left untreated. (encyclopedia.com)
- Because they can occur wherever neuroendocrine cells are found, neuroendocrine tumors come in a wide variety of types and have been classified according to their site of origin, usually either as digestive system , pancreatic or lung neuroendocrine tumors. (encyclopedia.com)
- Foregut tumors arise in the stomach or duodenum (first part of small intestine) and represent approximately 15% to 25% of neuroendocrine tumors. (encyclopedia.com)
- Midgut neuroendocrine tumors. (encyclopedia.com)
- Hindgut neuroendocrine tumors. (encyclopedia.com)
- Most neuroendocrine pancreatic tumors produce multiple hormones but usually there is excessive production of only one hormone. (encyclopedia.com)
- This is why neuroendocrine pancreatic tumors are often classified according to the predominant hormone secreted or resulting symptoms observed. (encyclopedia.com)
- These types of neuroendocrine lung tumors grow slowly and do not often spread beyond the lungs. (encyclopedia.com)
- Additionally, neuroendocrine tumors are sub-classified into "functionally active" and "functionally inactive" tumors. (encyclopedia.com)
- Functionally active neuroendocrine tumors display specific symptoms, such as the excessive release of specific neurohormones from the tumor cell, as described above for pancreatic neuroendocrine tumors. (encyclopedia.com)
- Grade 1 neuroendocrine carcinomas are also known as carcinoid tumors. (encyclopedia.com)
- Grade 2 include tumors such as atypical carcinoid tumors, medullary thyroid carcinomas, and some pancreatic endocrine tumors. (encyclopedia.com)
- Sutent is indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease. (drugs.com)
- The recommended dose of Sutent for pancreatic neuroendocrine tumors (pNET) is 37.5 mg taken orally once daily continuously without a scheduled off-treatment period. (drugs.com)
- PEN-221 is the lead candidate 'Pentarin' aimed at Neuroendocrine Cancer - PEN-221.Somatostatin receptor 2 (SSTR2) is frequently overexpressed on several types of solid tumors, including neuroendocrine tumors and small-cell lung cancer. (ronnyallan.net)
Tumor43
- Ni K, Bibbo M (1994) Fine needle aspiration of mammary carcinoma with features of a carcinoid tumor. (springer.com)
- Neuroendocrine carcinoma of the cervix is best defined separately:Neuroendocrine: Of, relating to, or involving the interaction between the nervous system and the hormones of the endocrine glands.Carcinoma: An invasive malignant tumor derived from epithelial tissue that tends to metastasize to other areas of the body. (wikipedia.org)
- To our knowledge, neuroendocrine carcinoma (NEC) has not been reported as a primary tumor of the jugular foramen. (thefreelibrary.com)
- Inguinal lymph nodes as the primary tumor site for neuroendocrine carcinoma represent a very unusual location, and have only been described in 2 patient series in the literature. (nih.gov)
- The removed lymph node showed histological and immunohistochemical characteristics of neuroendocrine differentiation (positive for synaptophysin, cytokeratin 20, neuron-specific enolase and chromogranin A). Although extensive investigations including repeated CT and NMR scans, classical endoscopy, wireless capsule endoscopy of the small intestine, octreotide- and MIBG scintigraphy were performed, no other primary tumor was found. (nih.gov)
- Patients with secondary neuroendocrine tumor of the breast and male patients were excluded from the study. (medworm.com)
- A case of neuroendocrine malignant tumor with capsule retention diagnosed by double-balloon enteroscopy. (springer.com)
- Neuroendocrine tumor of small bowel. (springer.com)
- I. To assess the objective tumor response rate (i.e. partial or complete responses as defined by the RECIST criteria) in patients with progressive metastatic neuroendocrine tumours given CCI-779. (knowcancer.com)
- A study exploring the genetic underpinnings of the newly classified high-grade neuroendocrine carcinoma has found that it is a rare but aggressive tumor with a high frequency of BRAF mutations. (cancernetwork.com)
- According to the study, in 2010 the World Health Organization reclassified gastrointestinal (GI) neuroendocrine neoplasms into two categories: neuroendocrine tumor (NET) and high-grade neuroendocrine carcinoma (NEC). (cancernetwork.com)
- Tumor Remission and tumor-infiltrating lymphocytes during chemoradiotherapy: predictive and prognostic markers in locally advanced esophageal squamous cell carcinoma. (bioportfolio.com)
- Nonsmall cell neuroendocrine carcinoma (NSCNEC) of the ovary is a rare and aggressive tumor commonly associated with other surface epithelial and germ cell neoplasms. (unboundmedicine.com)
- Large-cell neuroendocrine carcinoma (LCNEC) of the lung, which has been histologically categorized as high-grade neuroendocrine carcinoma with small-cell lung cancer (SCLC), is a highly malignant tumor with a poor prognosis. (aacrjournals.org)
- NEC presenting with a squamous cell carcinoma (SCC) component is referred to as a composite tumor. (scirp.org)
- Neuroendocrine tumor epidemiology: contrasting Norway and North America. (springermedizin.de)
- Neuroendocrine tumor of the gallbladder. (springermedizin.de)
- Pulmonary large cell neuroendocrine carcinoma: a true high-grade neuroendocrine tumor needing prospective therapeutic data. (nih.gov)
- Amphicrine carcinoma is a distinct type of carcinoma characterized by synchronous exocrine and endocrine differentiation within the same tumor cell. (ovid.com)
- Microscopically, the lesions had an organoid pattern, consisting of nests of large tumor cells with peripheral palisading, vesicular nuclei and prominent nucleoli reminiscent of large cell neuroendocrine carcinoma. (ovid.com)
- We have previously identified six novel marker genes for neuroendocrine tumor cells by using Affymetrix microarrays and advanced bioinformatics. (enets.org)
- Local tumor invasion represents the first step of the metastatic cascade of carcinomas, and requires changes in cell adhesion and migration properties of tumor cells. (enets.org)
- Assessment of tumor burden changes is essential for the management of well-differentiated gastroenteropancreatic neuroendocrine carcinoma (GEPNET). (enets.org)
- The patient had axillary and hepatic metastases at the time of diagnosis, and the clinical course suggests that this tumor behaves in an aggressive fashion, analogous to other small cell neuroendocrine carcinomas. (semanticscholar.org)
- Presence of a metachronous colon adenocarcinoma in a patient with nonfunctional pancreatic neuroendocrine tumor has not been reported before. (diva-portal.org)
- In 2002, after the diagnosis of an unresectable, nonfunctional pancreatic neuroendocrine tumor, interferon alpha-2b and octreotide were started. (diva-portal.org)
- Immunohistochemical study using neuroendocrine markers allowed a straightforward diagnosis of a low-grade neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder. (biomedcentral.com)
- NE-differentiated small-cell carcinoma is a very rare tumor comprising 0.5-2% of all prostatic carcinomas. (semanticscholar.org)
- Neuroendocrine Tumor (NET) is arising from cells throughout the diffuse endocrine system. (alliedacademies.org)
- Neuroendocrine tumor is thought to arise from cells throughout the diffuse system. (alliedacademies.org)
- The most common of which are carcinoid and pancreatic neuroendocrine tumor. (alliedacademies.org)
- An analysis of the SEER databases estimated that the incidence of neuroendocrine tumor in the United States was 5.25 cases per 100,000 people in the year 2004 [ 1 ]. (alliedacademies.org)
- Patients with neuroendocrine tumor may or may not have symptoms attributable to hormonal hyper secretion [ 2 , 3 ]. (alliedacademies.org)
- This tumor was distinctly different from the initial undifferentiated nasopharyngeal carcinoma treated in 2007. (cureus.com)
- Objective: To report a single institutional series of high-grade neuroendocrine carcinoma of the larynx (NCL), a very rare yet aggressive tumor. (elsevier.com)
- Recently, we have encountered large cell neuroendocrine carcinoma of the submandibular gland that was diagnosed at autopsy, but was difficult to distinguish from metastatic tumor. (biomedcentral.com)
- Pulmonary Large Cell Neuroendocrine Carcinoma, also known as large cell lung neuroendocrine carcinoma , is related to neuroendocrine carcinoma and neuroendocrine tumor , and has symptoms including fever , dyspnea and hemoptysis . (malacards.org)
- A man with multiple endocrine neoplasia type 1 who was diagnosed with a recurrent primary hyperparathyroidism underwent a distal pancreatic resection for a non-functional neuroendocrine tumor. (biomedcentral.com)
- In the context of our regular screening program, a large non-functional neuroendocrine tumor was diagnosed in the pancreatic head 15 months after the first pancreatic surgery. (biomedcentral.com)
- Cases were then segregated into large cell neuroendocrine carcinomas, mixed large cell neuroendocrine carcinomas (in which at least one portion of the tumor was a large cell neuroendocrine carcinoma), or large cell carcinomas on the basis of morphology and differentiation. (elsevier.com)
- It involves the staining of the tumor with a monoclonal antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient. (biospraymakassar.com)
- Due to calcitonin positivity and coexistence of a thyroid nodule, the tumor raised the differential diagnosis of medullary thyroid carcinoma. (umn.edu)
- The recommended dose of Sutent for gastrointestinal stromal tumor (GIST) and advanced renal cell carcinoma (RCC) is one 50 mg oral dose taken once daily, on a schedule of 4 weeks on treatment followed by 2 weeks off (Schedule 4/2). (drugs.com)
Differentiation14
- [ 38 ] Interestingly, a small percentage of oropharyngeal HPV-related carcinomas show extensive neuroendocrine differentiation and therefore are better classified as neuroendocrine carcinomas. (medscape.com)
- Sapino A, Righi L, Cassoni P et al (2001) Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. (springer.com)
- METHODS: Patients with more than 50% neuroendocrine differentiation identified in the histopathological examination between January 2010 and January 2015 and who had no other focus on imaging were evaluated retrospectively from the hospital registry system. (medworm.com)
- CONCLUS ON: The most widely used specific markers of neuroendocrine differentiation are chromogranin and synaptophysin. (medworm.com)
- Neuroendocrine carcinomas (NECs) are classified as a subgroup of neuroectodermal neoplasms with epithelial differentiation, which are heterogeneous and vary from low to high grade malignant. (scirp.org)
- This series highlights a rare variant of pulmonary carcinoma showing synchronous exocrine and endocrine differentiation. (ovid.com)
- An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. (mycancergenome.org)
- The existence of non-small cell lung carcinoma with neuroendocrine differentiation as a distinct entity and its relevance for prognostic and treatment purposes is controversial. (edu.au)
- Disease specific and overall survival is not influenced by NE differentiation and therefore non-small cell lung carcinoma with neuroendocrine differentiation should not be a subclass distinct from the other NSCLC. (edu.au)
- Since the introduction of immunohistochemistry, there is an increasing interest in neuroendocrine (NE) differentiation in prostatic carcinomas. (semanticscholar.org)
- Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate. (semanticscholar.org)
- Low-grade tubular-mucinous renal neoplasm with neuroendocrine differentiation: a histological, immunohistochemical and ultrastructural study. (openrepository.com)
- Neuroendocrine differentiation in hepatocellular carcinoma. (bvsalud.org)
- Accurate differentiation of large cell neuroendocrine carcinoma from large cell carcinoma is important because it identifies those patients at highest risk for the development of recurrent lung cancer. (elsevier.com)
Abstract3
- abstract = "The purpose of this study was to detect human papillomavirus (HPV) infection in laryngeal neuroendocrine carcinoma (LNEC) and to explore the possible relationship between HPV-induced malignant transformation and prognosis in LNEC. (rug.nl)
- Gatalica Z, Feldman R, Ghazalpour A, Vranic S. Characterization of neuroendocrine breast carcinomas for biomarkers of therapeutic options [abstract]. (aacrjournals.org)
- abstract = "Purpose: Primary neuroendocrine carcinoma of the breast (NECB) is a rare distinct type of breast carcinoma. (elsevier.com)
Squamous20
- During the past two decades, HPV has emerged as an important etiologic factor for a subset of head and neck squamous cell carcinomas. (medscape.com)
- HPV-related squamous cell carcinomas particularly affect the oropharynx, often show a nonkeratinizing morphology, and are associated with a better prognosis when compared to conventional keratinizing, smoking-related squamous cell carcinomas. (medscape.com)
- Small-cell carcinoma (SCC) of the cervix is an exceptional member of the neuroendocrine group of cervical carcinomas that is frequently intermixed with a non-SCC component in the form of an adenocarcinoma (ADC) or squamous carcinoma. (wikipedia.org)
- The relationship between HPV, improved prognosis and good response to therapy for squamous cell carcinoma of the head and neck may also be true for a subset of LNEC. (rug.nl)
- A multimodality approach using concurrent chemoradiotherapy (CRT) followed by esophagectomy has been the standard treatment in patients with locally advanced esophageal squamous cell carcinoma (ESCC). (bioportfolio.com)
- Clinical tools are unavailable for accurately predicting the pathological responses to chemoradiotherapy (CRT) of patients with esophageal squamous cell carcinoma (ESCC) before surgery. (bioportfolio.com)
- Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma. (bioportfolio.com)
- Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody. (bioportfolio.com)
- Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and adenocarcinoma is most common in N. (bioportfolio.com)
- The prognosis of locally advanced esophageal squamous cell carcinoma is poor,the role of chemotherapy as neoadjuvant therapy in locally advanced esophageal cancer has been established, whi. (bioportfolio.com)
- Recently, myoferlin was identified as a promising target and biomarker in non-small-cell lung cancer, breast cancer, pancreatic adenocarcinoma, hepatocellular carcinoma, colon cancer, melanoma, oropharyngeal squamous cell carcinoma, head and neck squamous cell carcinoma, clear cell renal cell carcinoma and endometrioid carcinoma. (medworm.com)
- Hematoxylin and eosin-stained sections were subclassified as: 243 adenocarcinoma (ACA), 272 squamous cell carcinoma (SCC), 35 large cell carcinoma, 32 non-small cell carcinoma NOS, and 6 other (carcinosarcoma, giant cell carcinoma). (edu.au)
- SNP is more likely to be expressed in adenocarcinoma (P=0.01) and N-CAM in squamous-cell carcinoma (P=0.008). (edu.au)
- We found a single report describing one patient in whom sNEC developed ten years after the initial treatment of head and neck squamous cell carcinoma (SCC) [6] . (cureus.com)
- Squamous cell carcinoma accounts for less than 10 percent of cancers of unknown primary. (mskcc.org)
- Some lung cancers are squamous cell carcinoma. (mskcc.org)
- 2013). 'Prognostic Impact of Histology in Patients with Cervical Squamous Cell Carcinoma, Adenocarcinoma and Small Cell Neuroendocrine Carcinoma', Asian Pacific Journal of Cancer Prevention , 14(9), pp. 5355-5360. (waocp.org)
- This study aimed to evaluate theprognostic impact of histological type on survival and mortality in patients with cervical squamous cell carcinoma(SCC), adenocarcinoma (ADC) and small cell neuroendocrine carcinoma (SNEC). (waocp.org)
- Squamous cell carcinoma of unknown primary is most often found in lymph nodes in the neck (called the cervical lymph nodes). (cancer.ca)
- Squamous cell carcinoma of unknown primary can also be found in lymph nodes in the groin (called the inguinal lymph nodes). (cancer.ca)
Neoplasms11
- Laryngeal epithelial neuroendocrine neoplasms are all malignant lesions. (hindawi.com)
- 2 ], the larynx has received increasing attention in the potential for development of different neuroendocrine neoplasms there. (hindawi.com)
- Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study. (springer.com)
- ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. (springer.com)
- In 8 cases, NSCNEC was associated with other epithelial neoplasms, including mucinous neoplasms of low malignant potential, mucinous carcinoma, endometrioid carcinoma, mixed endometrioid and mucinous carcinoma, and a high-grade carcinoma, not otherwise specified. (unboundmedicine.com)
- 68Galabeled DOTATOC as a PET-tracer has shown both high sensitivity and specificity for neuroendocrine neoplasms detection and staging [ 11 - 14 ]. (omicsonline.org)
- Neuroendocrine carcinomas (NECs) are rare neoplasms that widely occur in various organs. (scirp.org)
- Neuroendocrine Tumours (NEC), are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. (alliedacademies.org)
- Our review of the literature revealed that further research is needed, focusing on neuroendocrine carcinomas of the esophagus and how this entity differs from some of the more well-known neuroendocrine neoplasms in terms of management. (cureus.com)
- Neuroendocrine carcinoma of the esophagus is classified within the gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) based on the 2010 World Health Organization (WHO) classification system. (cureus.com)
- These statistics help illustrate the rare occurrence of the entity discussed in this case report, compared to other neuroendocrine neoplasms within the general population. (cureus.com)
LCNEC14
- Whereas large-cell neuroendocrine carcinoma (LCNEC) is a subgroup of large-cell carcinoma, that has characteristics similar to SCLC. (redorbit.com)
- Large cell neuroendocrine carcinoma of the lung (LCNEC) is a highly malignant neoplasm arising from transformed epithelial cells originating in tissues within the pulmonary tree. (wikipedia.org)
- LCNEC is often generically grouped among the non-small cell lung carcinomas. (wikipedia.org)
- This is a Phase 1a/1b study of SC-002 in patients with relapsed small cell lung cancer (SCLC) or large cell neuroendocrine carcinoma (LCNEC). (clinicaltrials.gov)
- Part 1A is a dose escalation study in patients with small cell lung cancer or large cell neuroendocrine carcinoma with cytologically confirmed, limited or extensive SCLC or LCNEC that have relapsed or refractory limited or extensive disease following no more than 2 prior chemotherapy regimens. (clinicaltrials.gov)
- We analyzed 70 UUT-NEC patients, including 68 with small cell neuroendocrine carcinoma (SCNEC) and large cell neuroendocrine carcinoma (LCNEC) reported between 1985 and 2017 and 2 treated at our hospital. (urotoday.com)
- Although large-cell neuroendocrine carcinoma (LCNEC) of the lung shares many clinical characteristics with small-cell lung cancer (SCLC), little is known about its molecular features. (aacrjournals.org)
- Previous genomic studies have identified two mutually exclusive molecular subtypes of large-cell neuroendocrine carcinoma (LCNEC): the RB1 mutated (mostly comutated with TP53 ) and the RB1 wild-type groups. (aacrjournals.org)
- This case report describes a 77-year-old man with a large cell neuroendocrine carcinoma (LCNEC) of the lung and metastases from this primary cancer in the prostate. (jcancer.org)
- We herein report a case of prostatic metastasis of pulmonary large cell neuroendocrine carcinoma (LCNEC). (jcancer.org)
- 1] on the efficacy of different chemotherapeutic regimens in a large series of 128 patients with stage IV large cell neuroendocrine carcinoma (LCNEC) of the lung. (ersjournals.com)
- Pulmonary neuroendocrine cancers (NECs) are generally categorized by grade: high-grade (SCLC, LCNEC), intermediate-grade (atypical carcinoid), and low-grade (typical carcinoid). (jnccn.org)
- In our centre, we diagnose a case of Large-Cell Neuroendocrine Carcinoma (LCNEC) of the, endometrium in an 82 y old female. (alliedacademies.org)
- 74 Large cell neuroendocrine carcinoma of the lung (LCNEC) is a highly malignant neoplasm arising from. (malacards.org)
Malignant4
- A possible explanation for the presence of neuroendocrine carcinomas within the lymph nodes is malignant transformation of preexisting intranodal epithelial nests, which have previously been described in lymph nodes located close to the salivary glands, thyroid gland, breast tissue and pancreas. (nih.gov)
- According to the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm, it is classified either as small or large cell neuroendocrine carcinoma. (mycancergenome.org)
- A high grade malignant neoplasm that arises from the lung and is characterized by the presence of large neuroendocrine cells. (mycancergenome.org)
- Merkel cell carcinoma is a rare disease that occurs when malignant (cancer) cells form in the skin. (dvohmg.com)
Tumours9
- Prof Sandip Patel speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about the DART study, which examined the administration of ipilimumab plus nivolumab to achieve dual checkpoint inhibition in a cohort of patients with rare neuroendocrine tumours. (ecancer.org)
- By disease indication type, the gastric neuroendocrine tumours segment is the largest segment in terms of market value as well as growth rate. (openbroadcast.de)
- Pancreatic neuroendocrine tumours (PTENs) are a heterogeneous group of tumours that develop from neuroendocrine cells of the pancreas [1]. (termedia.pl)
- Pancreatic neuroendocrine tumours comprise a rare group of pancreatic tumours and represent about 1-2% of all tumours developing within this organ [2]. (termedia.pl)
- The potential of neuroendocrine cells to produce and secrete peptides and/or biogenic amines affecting the clinical presentation of the disease thus determines their division into functioning and non-functioning pancreatic neuroendocrine tumours (functioning, F-PTEN and non-functioning, NF-PTEN). (termedia.pl)
- General accessibility of cross-sectional imaging of the abdomen has caused a significantly increasing rate of incidentally revealed non-functioning pancreatic neuroendocrine tumours in recent years. (termedia.pl)
- The group of NF-PTEN represents the majority of neuroendocrine tumours of the pancreas and is estimated at 60-90% [3]. (termedia.pl)
- Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast? (semanticscholar.org)
- Neuroendocrine carcinomas are different types of tumours that start in the neuroendocrine system . (cancer.ca)
Cancers11
- Large-cell carcinoma (LCC), like small-cell carcinoma (SCC) is very rare and only accounts for about 5% of all cervical cancers. (wikipedia.org)
- Primary neuroendocrine carcinoma is very rare and accounts for less than 5% of prostate cancers. (healthengine.com.au)
- NEC patients should receive chemotherapy as soon as possible after diagnosis but research on how to treat NEC and the development of treatment guidelines are mainly done at clinics specialized in neuroendocrine cancers called Centers of Excellence (CoE). (diva-portal.org)
- Coexisting cancers: a mixture of neuroendocrine carcinoma and adenocarcinoma in the gallbladder: A case report. (springermedizin.de)
- Patients treated with radiation have an increased risk of developing second cancers, of which carcinomas, sarcomas, and hematological malignancies have most commonly been reported. (cureus.com)
- Most commonly reported second malignancies include carcinomas and hematologic cancers in the low-dose areas, and sarcomas in the high-dose areas [4] . (cureus.com)
- About 85% of all cancers in the UK are carcinomas. (macmillan.org.uk)
- Some cancers of unknown primary contain neuroendocrine cells. (mskcc.org)
- Most cancers of unknown primary are carcinomas. (cancer.ca)
- Under the microscope, neuroendocrine cancers of the cervix appear identical to those originating in the lung. (damncancer.com)
- The FIGO system is the one used to describe all cervical cancers, while the two-tiered system used to describe small cell carcinomas of the lung is also used (see tables with staging). (damncancer.com)
Endocrine carcinoma2
- Main geographies across the entire globe are assessed and the trends, developments, opportunities, drivers and challenges in each region and sub region that have an influence over the growth of the market in the respective region are studied to get a clear picture of the global endocrine carcinoma market. (pharmiweb.com)
- We report a rare case of an ileal endocrine carcinoma that produced ACTH and induced hypercortisolism. (endocrine-abstracts.org)
Neoplasm3
- A total of 553 patients with neuroendocrine neoplasm (NEN) from the Northern region of Sweden were included and analysed retrospectively to identify patients with NEC diagnosed over a 17-year period (1997-2014). (diva-portal.org)
- Systematic treatment strategy for Neuroendocrine carcinoma (NEC) has not been established.Extra-pulmonary NEC is a rare and highly aggressive neoplasm for which the optimal chemotherapy remains unclear.Guidelines for treating extra-pulmonary NEC advocate the use of Platinum-based chemotherapy, although limited studies have been reported.The objective this study was to evaluate the clinical outcomes of the NEC treated with chemotherapy. (esmo.org)
- Primary calcitonin-secreting neuroendocrine carcinoma of the larynx is a rare neuroectodermal neoplasm currently classified as moderately differentiated (atypical carcinoid/WHO classification) neuroendocrine carcinoma of the larynx. (umn.edu)
Gastrointestinal tract5
- Ninety-seven percent of neuroendocrine carcinomas are located in the gastrointestinal tract or in the bronchopulmonary tree. (nih.gov)
- Because small cell and large cell neuroendocrine carcinomas of the gastrointestinal tract are usually found at an advanced stage, treatment often begins with a combination of platinum-based chemotherapy drugs. (mskcc.org)
- 1. Assess the clinical activity defined by response rate of irinotecan and cisplatin in untreated patients with metastatic or unresectable high grade neuroendocrine carcinoma of the gastrointestinal tract. (clinicaltrials.gov)
- 1. To assess the safety profile of irinotecan and cisplatin in untreated patients with metastatic or unresectable high grade neuroendocrine carcinoma of the gastrointestinal tract. (clinicaltrials.gov)
- This randomized phase II trial studies how well temozolomide and capecitabine work compared to standard treatment with cisplatin or carboplatin and etoposide in treating patients with neuroendocrine carcinoma of the gastrointestinal tract or pancreas that has spread to other parts of the body (metastatic) or cannot be removed by surgery. (centerwatch.com)
Diagnosis13
- The final pathologic diagnosis was neuroendocrine carcinoma. (thefreelibrary.com)
- The pathomorphological features and neuroendocrine markers (CD56, CgA, Syn), epithelial markers (CKpan, CAM5.2) and nephrogenic markers (PAX2, PAX8) are important for the diagnosis. (urotoday.com)
- The following tests may be performed to confirm a diagnosis of large cell neuroendocrine carcinoma or small cell carcinoma. (mskcc.org)
- The diagnosis: stage two grade two invasive ductal carcinoma - an aggressively growing cancer. (medworm.com)
- The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. (springer.com)
- Bacchetti S, Pasqual EM, Rinaldo A, Ferlito A (2013) Current Advances in Diagnosis of Hepatic Metastases from Neuroendocrine Carcinomas. (omicsonline.org)
- A diagnosis of high-grade large cell neuroendocrine carcinoma of the uterine cervix was made with FIGO stage IIA2. (bmj.com)
- We discuss the pathological aspect and diagnostic tool of immunohistochemically stain in 83 y old woman who present with postmenopausal bleeding, in which her histopathology diagnosis was issued as mixed type tumour papillary serous and large neuroendocrine, with FIGO nuclear grade III. (alliedacademies.org)
- Microscopic examination revealed multiple fragments of endometrial tissue and, report was issued with a diagnosis of combined endometrial carcinoma with a component of papillary serous endometroid and large neuroendocrine carcinoma. (alliedacademies.org)
- A diagnosis of poorly differentiated (high-grade) non-small cell neuroendocrine carcinoma was made after a histological analysis and immunostaining. (cureus.com)
- The histopathological diagnosis was large cell neuroendocrine carcinoma of the submandibular gland. (biomedcentral.com)
- At histology, the diagnosis of a neuroendocrine carcinoma with one lymph node metastasis was established. (biomedcentral.com)
- The initial diagnosis for both cases was poorly differentiated grade 3 small-cell neuroendocrine carcinoma, based on imaging characteristics and the pathology of liver biopsies. (biomedcentral.com)
Epithelial2
- however, there are also some specialised epithelial (lining) cells called neuroendocrine cells. (healthengine.com.au)
- Carcinoma is a type of cancer that starts in epithelial tissues. (cancer.ca)
Global neuroendocrine carcinoma15
- GlobalData has estimated that the global neuroendocrine carcinoma ther. (bio-medicine.org)
- The report is an essential source of information and analysis on the global neuroendocrine carcinoma market. (bio-medicine.org)
- Most importantly, the report provides valuable insights on the pipeline products within the global neuroendocrine carcinoma sector. (bio-medicine.org)
- GlobalData has estimated that the global neuroendocrine carcinoma therapeutics market was worth $127m in 2011 and is forecast to grow at Compound Annual Growth Rate (CAGR) of 17.9% to reach $475m by 2019. (bio-medicine.org)
- Analysis of the current and future competition in the global neuroendocrine carcinoma market. (bio-medicine.org)
- Develop business strategies by understanding the trends shaping and driving the global neuroendocrine carcinoma market. (bio-medicine.org)
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global neuroendocrine carcinoma market in the future. (bio-medicine.org)
- The research report on global neuroendocrine carcinoma market covers analysis on key companies dealing with neuroendocrine carcinoma. (pharmiweb.com)
- The weighted market analysis on global neuroendocrine carcinoma market delivers value to the reader by providing drinkable insights, ready to use statistical analysis and recommendations without biasness in order to plan future expansion strategies and also to gain stability in the changing dynamics of the global market. (pharmiweb.com)
- It has also included an in-depth analysis on the various key players participating in the global neuroendocrine carcinoma marketalong with key developments taking place during the 2017-2027 timeline. (openbroadcast.de)
- This research report also unveils various opportunities, trends, drivers and restraints impacting the growth of the global neuroendocrine carcinoma market. (openbroadcast.de)
- The global neuroendocrine carcinoma market is anticipated to witness high growth during the period of forecast to reach a valuation of about US$ 2.5 Bn by the end of the forecasted year from an estimate of around US$ 1.5 Mn in 2017. (openbroadcast.de)
- The global neuroendocrine carcinoma market is segmented on the basis of disease indication type treatment type, end user and by region. (openbroadcast.de)
- By end user, hospitals segment is anticipated to the largest segment leading the global neuroendocrine carcinoma market with a high CAGR of 8.2% during the period of assessment, owing to high infrastructure investment towards adopting newer detection technologies. (openbroadcast.de)
- The global neuroendocrine carcinoma market research report has included key players involved in the market. (openbroadcast.de)
Gastroenteropancreatic neuroendocrine carcinoma1
- How effective is the treatment of gastroenteropancreatic neuroendocrine carcinoma outside Centers of Excellence? (diva-portal.org)
Aggressive10
- My brother has very aggressive, widely metastasized neuroendocrine carcinoma. (cancercompass.com)
- Neuroendocrine carcinoma (NEC) is rare and highly aggressive form of cancer that is treated by chemotherapy. (diva-portal.org)
- Neuroendocrine tumour of the uterine cervix is an extremely aggressive cancer with the late presentation-the need for a more rigorous treatment protocol as well as potential screening methods could improve outcomes for these patients. (bmj.com)
- However, recent studies suggest that targeted therapies could be a therapeutic option for this group of highly aggressive carcinomas. (enets.org)
- Large Neuroendocrine Carcinoma (LNEC) tends to be high grade and is known to behave in aggressive fashion. (alliedacademies.org)
- High-grade neuroendocrine carcinoma (NEC) of the esophagus is an extremely aggressive and rare disease, which is still not well understood. (cureus.com)
- Neuroendocrine carcinoma (Merkel cell) - Is a rare and aggressive cancer that begins in the hormone-producing cells beneath the skin, in the hair follicles and also is found on the head and neck. (dvohmg.com)
- Small cell neuroendocrine prostate carcinoma is a very aggressive disease with a poor prognosis, even in its localized form. (elsevier.com)
- One of the many aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. (biospraymakassar.com)
- Small cell carcinoma is a very aggressive type of neuroendocrine carcinoma that spreads quickly. (cancer.ca)
Chemotherapy5
- In the small cell neuroendocrine carcinoma group, a combination of chemotherapy and radiotherapy was applied. (hindawi.com)
- Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. (springer.com)
- 42 Chemotherapy in the Treatment of Progressive, Undifferentiated Neuroendocrine Carcinomas: a Single-Center Experience. (enets.org)
- neuroendorine carcinomas tend to be sensitive to chemotherapy. (justanswer.com)
- A 51-year-old Chinese woman diagnosed with gastral neuroendocrine carcinoma by gastroscope was referred to our hospital- Department of Chemotherapy, the cancer hospital of Guangxi medical University (Nanning, China) in August 2014 ( Figure 1A ). (alliedacademies.org)
Adenocarcinoma5
- More frequently, small sections of neuroendocrine carcinoma occur within the far more common adenocarcinoma form . (healthengine.com.au)
- Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. (springermedizin.de)
- Herein, we report the first case of a patient with EGFR-mutant lung adenocarcinoma with a long-lasting response to first-line erlotinib treatment who acquired resistance to treatment because of acquisition of both EGFR-T790M mutation and "high-grade" large cell neuroendocrine transformation. (ovid.com)
- Clinicopathological Characteristics of Microscopic Tubal Intraepithelial Metastases from Adenocarcinoma and Small Cell Neuroendocrine Carcinoma of the Uterine Cervix. (bvsalud.org)
- Though the possibilities of neuroendocrine carcinoma in colon are very rare, if unfortunately one is affected by this disease, the health of the patient becomes worse than patients who suffer from adenocarcinoma. (biospraymakassar.com)
Laryngeal6
- Few studies have addressed the etiologic role of high-risk HPV in laryngeal neuroendocrine carcinomas. (medscape.com)
- In 2013, Halmos et al [ 47 ] reported a series of 10 cases of laryngeal neuroendocrine carcinomas ranging from well- to poorly differentiated types. (medscape.com)
- Thompson et al [ 45 ] and Alos et al [ 49 ] have also investigated the role of HPV in neuroendocrine carcinomas of the head and neck and in their series they included three and seven laryngeal cases, respectively. (medscape.com)
- Laryngeal neuroendocrine carcinomas (LNECs) are rare and highly heterogeneous which present a wide spectrum of pathological and clinical manifestations. (hindawi.com)
- Is human papillomavirus involved in laryngeal neuroendocrine carcinoma? (rug.nl)
- Method: A retrospective chart review of high-grade laryngeal neuroendocrine carcinomas at a single institution, including small- and large-cell neuroendocrine carcinomas. (elsevier.com)
Breast carcinomas4
- Neuroendocrine breast carcinomas are rare but may represent either metastatic or primary lesions. (springer.com)
- We observed in our study that solid neuroendocrine breast carcinomas are characterized by the expression of estrogen and progesterone receptors as well as GCDFP-15 and/or mammaglobin. (springer.com)
- Lopez-Bonet E, Alonso-Ruano M, Barraza G et al (2008) Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling. (springer.com)
- Molecular profiles of 40 breast carcinomas with neuroendocrine features [ER/PR+ (n=20), HER2+ (n=1) and TNBC (n=14)] were assessed (all female patients, mean age: 60.3 years, range: 39-83 years). (aacrjournals.org)
Transitional cell carc2
- MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance. (biomedsearch.com)
- Combined small-cell and transitional cell carcinoma of the renal pelvis. (openrepository.com)
Metastases3
- Three patients (two with small cell carcinoma and one with large cell carcinoma) died of extensive metastases at 3 months, 4 months and 9 months after operation, while five patients were well, without recurrence or distant metastasis for follow-up period of one to nine years. (urotoday.com)
- Neuroendocrine hepatic metastases may be difficult to identify on CT, as they may be isointense to the liver on portal venous phase. (omicsonline.org)
- 19 ] found that on MRI 75% of neuroendocrine liver metastases appeared as low signal intensity on T1- and high signal intensity on T2-weighted images, with 94% of metastases being hypervascular on hepatic arterial phase post-gadolinium images and 15% of hepatic metastases being seen only on the immediate postgadolinium images [ 19 ]. (omicsonline.org)
Hepatic2
- At first, because of his cervical swelling, hepatic carcinoma with neck metastasis was suspected. (biomedcentral.com)
- Primary hepatic neuroendocrine carcinoma (PHNEC) is extremely rare. (biomedcentral.com)
Immunohistochemistry3
- Immunohistochemistry of the tumour cells showed strong positivity for the neuroendocrine markers synaptophysin and a very high Ki67 proliferation index. (bmj.com)
- This study assesses the frequency and biologic and prognostic significance of neuroendocrine (NE) expression of synaptophysin (SNP), chromogranin (Ch), and neural cell adhesion molecule (N-CAM) using tissue microarray (TMA) and immunohistochemistry. (edu.au)
- This report indicates total biopsy and immunohistochemistry are necessary for diagnosing large cell neuroendocrine carcinoma properly. (biomedcentral.com)
Lung carcinoma2
- It is currently considered to be a subtype of large cell lung carcinoma. (wikipedia.org)
- Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? (nih.gov)
Cervical Large Cell Neuroendocrine Carcinoma2
- Cervical Large Cell Neuroendocrine Carcinoma is related to large cell neuroendocrine carcinoma and cystadenoma . (malacards.org)
- An important gene associated with Cervical Large Cell Neuroendocrine Carcinoma is CHGA (Chromogranin A). Affiliated tissues include cervix . (malacards.org)
Immunohistochemical4
- Neuroendocrine carcinoma of the parotid gland: a report of two cases with ultrastructural and immunohistochemical studies. (curehunter.com)
- The histological, immunohistochemical, and ultrastructural features of a primary small cell neuroendocrine carcinoma of the renal parenchyma are described. (openrepository.com)
- Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature. (openrepository.com)
- Immunohistochemical staining methods is specifically used for neuroendocrine markers. (biospraymakassar.com)
Cervix6
- There are two types of neuroendocrine carcinomas of the cervix: small-cell and large-cell. (wikipedia.org)
- Because of the distinct natural history of small cell carcinoma of the uterine cervix, and because patients with this condition are considered to have a systemic disease, the treatment strategies for this disease are different from those of other carcinomas" (ajronline.org). (wikipedia.org)
- We report a case of large cell neuroendocrine carcinoma of the uterine cervix. (bmj.com)
- 12 A cervix carcinoma that has material basis in neuroendocrine tissue and is characerized by a diffuse, organoid, trabecular, or cord-like pattern of neoplastic cells with abundant cytoplasm, large nuclei, prominent nucleoli, and a high mitotic rate. (malacards.org)
- Symptoms of neuroendocrine carcinoma of the cervix? (damncancer.com)
- How is neuroendocrine carcinoma of the cervix diagnosed? (damncancer.com)
Large27
- Two of their cases (one moderately differentiated neuroendocrine carcinoma and one large cell neuroendocrine carcinoma) were positive for high-risk HPV (HPV-18 and HPV-16, respectively) using a DNA-based polymerase chain reaction (PCR) platform targeting HPV consensus primers for GP5+/6+ and HPV-16 and HPV-18 specific primers. (medscape.com)
- The major categories of LNECs are typical carcinoid, atypical carcinoid, small cell neuroendocrine carcinoma, and large cell neuroendocrine carcinoma. (hindawi.com)
- Gastrointestinal small cell carcinoma and large cell carcinoma are usually diagnosed at an advanced stage, after they have spread to the lymph nodes or other organs. (mskcc.org)
- an atypical carcinoid was positive for HPV16 and a large-cell neuroendocrine carcinoma for HPV18. (rug.nl)
- Large cell neuroendocrine carcinoma primarily in the pericar. (lww.com)
- Large cell neuroendocrine carcinoma primarily in the pericardium: A case report and literature review. (lww.com)
- Microscopically, the neuroendocrine component was usually composed of large and/or intermediate oval to round cells. (unboundmedicine.com)
- Shimizu K, Goto T, Maeshima A, Oyamada Y, Kato R. Prostatic Metastasis of Pulmonary Large Cell Neuroendocrine Carcinoma. (jcancer.org)
- To compare the presenting and prognostic characteristics of patients with large cell neuroendocrine lung cancer (LCNELC) with those of patients with small cell lung cancer (SCLC) or other large cell carcinomas (OLCs) and to compare overall survival (OS) and lung cancer-specific survival (LCSS) rates for patients undergoing definitive resection without radiotherapy (S-NoRT). (nih.gov)
- Therefore, LCNELC should continue to be classified and treated as a large cell carcinoma. (nih.gov)
- Identity, similarity, and difference between large cell neuroendocrine carcinoma and small cell carcinoma. (nih.gov)
- For the small and large cells poorly differentiated neuroendocrine carcinomas (PDNECs) emergency treatment remains the combination cisplatin/etoposide. (enets.org)
- There are 4 clinical trials for large cell lung neuroendocrine carcinoma, of which 4 are open and 0 are completed or closed. (mycancergenome.org)
- Of the trials that contain large cell lung neuroendocrine carcinoma as an inclusion criterion, 1 is phase 1/phase 2 (1 open) and 3 are phase 2 (3 open). (mycancergenome.org)
- EGFR and SSTR2 are the most frequent gene inclusion criteria for large cell lung neuroendocrine carcinoma clinical trials [ 3 ]. (mycancergenome.org)
- Nivolumab, pen-221, and etoposide are the most common interventions in large cell lung neuroendocrine carcinoma clinical trials. (mycancergenome.org)
- It was report it as mixed type tumour papillary serous and large neuroendocrine, with FIGO nuclear grade III, the endocrine origin of the tumour was confirmed by immunohistochemically endocrine marker CD56 and NSE. (alliedacademies.org)
- Large cell neuroendocrine carcinoma in the salivary glands is rare. (biomedcentral.com)
- We report a second case of large cell neuroendocrine carcinoma of the submandibular gland diagnosed at autopsy, and a review of the literature. (biomedcentral.com)
- To the best of our knowledge, only eight cases of large cell neuroendocrine carcinoma in the salivary glands, including our case, have been reported. (biomedcentral.com)
- Large cell neuroendocrine carcinoma has poor prognosis like SCC. (biomedcentral.com)
- An important gene associated with Pulmonary Large Cell Neuroendocrine Carcinoma is SYP (Synaptophysin). (malacards.org)
- The objective of this study was to report the outcome of surgical resection in patients with large cell neuroendocrine carcinomas. (elsevier.com)
- Cox proportional hazards model analysis incorporating the variables of age, sex, histology, and stage estimated the effect of large cell neuroendocrine carcinomas and mixed large cell neuroendocrine carcinomas on recurrence and death. (elsevier.com)
- Overall survival by histologic subtype at 5 years was 30.2% for patients with large cell neuroendocrine carcinomas (n = 45), 30.3% for patients with mixed large cell neuroendocrine carcinomas (n = 11), and 71.3% for patients with large cell carcinomas (n = 21). (elsevier.com)
- Survival was significantly worse for patients with large cell neuroendocrine carcinomas than for patients with large cell carcinomas (P = .013). (elsevier.com)
- 001). Conclusion: Patients with large cell neuroendocrine carcinomas have a significantly worse survival after resection than patients with large cell carcinomas, even in stage I disease. (elsevier.com)
Therapeutics4
- http://www.reportlinker.com/p0606218/Neuroendocrine-Carcinoma-Therapeu...Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market. (bio-medicine.org)
- These factors will accelerate the growth of the neuroendocrine carcinoma therapeutics market. (bio-medicine.org)
- Key topics covered include a strategic competitor assessment, market characterization, and unmet needs and their implications for the neuroendocrine carcinoma therapeutics market. (bio-medicine.org)
- sales and marketing efforts by identifying the best opportunities for Neuroendocrine Carcinoma therapeutics in each of the markets covered. (bioportfolio.com)
Synaptophysin1
- Immunohistochemically, the expression rates of neuroendocrine markers CD56, chromogranin A (CgA) and synaptophysin (Syn) were 6/8, 4/8, and 8/8 respectively. (urotoday.com)
Moderately differentiated neuroendocrine carcinoma1
- Final pathology showed moderately differentiated neuroendocrine carcinoma. (umn.edu)
Types of neuroendocrine carcinomas1
- Certain types of neuroendocrine carcinomas may respond better to treatments other than the current standard treatment of cisplatin and etoposide. (centerwatch.com)
Renal cell carc2
- In this case report, we present our experience in a patient who came for diagnostic workup of renal cell carcinoma and a rectal mass was detected incidentally during CT imaging which turned out to be a neuroendocrine carcinoma on histopathologic examination. (plexusmd.com)
- Sutent is indicated for the treatment of advanced renal cell carcinoma. (drugs.com)
Cancer22
- What is Prostate Cancer (Neuroendocrine Carcinoma of the Prostate)? (healthengine.com.au)
- If cancer arises in the neuroendocrine cells of the prostate , it is known as neuroendocrine carcinoma of the prostate . (healthengine.com.au)
- The predisposing factors that result in the neuroendocrine variant of prostate cancer remain unclear. (healthengine.com.au)
- This type of cancer occurs in the neuroendocrine system of human body and produce hormones similar to neuroendocrine cells. (grandviewresearch.com)
- In addition, increasing investments in R&D for the development of cost-effective next generation sequencing tools that are used to develop new therapies for cancer treatment and the ongoing clinical trials are expected to accelerate the neuroendocrine carcinoma market growth. (grandviewresearch.com)
- My father was diagnosed with neuroendocrine carcinoma of the submandibular gland, primary cancer, diagnosed by FNA, CT and PET scans. (justanswer.com)
- Colon carcinoma ranks third in frequency among primary sites of cancer in both men and women in western countries. (diva-portal.org)
- Models of neuroendocrine prostate cancer. (semanticscholar.org)
- Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions]. (semanticscholar.org)
- Ectopic Cushing syndrome due to neuroendocrine prostatic cancer. (semanticscholar.org)
- Neuroendocrine carcinoma is also called, Merkel Cell or trabular cancer. (dvohmg.com)
- Merkel cell carcinoma is a rare type of skin cancer, that frequently starts on sun exposed areas of the head, neck, and extremities. (dvohmg.com)
- After Merkel cell carcinoma has been diagnosed, tests are done to find out if cancer cells have spread to other parts of the body. (dvohmg.com)
- Within the framework of the Rare Cancer Network Study, we examined 30 patients suffering from small cell neuroendocrine prostate cancer, either in an early/localized or an advanced/metastatic stage. (elsevier.com)
- Carcinomas are the most common type of cancer cell. (macmillan.org.uk)
- In general, the symptoms of neuroendocrine cancer do not appear to differ significantly from those of other types of cervical cancer [9]. (damncancer.com)
- Surveys show reports reveal that most of the cases of neuroendocrine cancer end with the death of the patient. (biospraymakassar.com)
- Though neuroendocrine colon carcinoma depends on which stage the tumour is in Standard cases have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. (biospraymakassar.com)
- This method assists doctors in dealing with the severity of the neuroendocrine colon cancer and helps to determine the most helpful medication and treatment for it. (biospraymakassar.com)
- Neuroendocrine colon cancer has a bad prognosis and surgery is not always a guaranteed treatment so surgery may not even cure the patient. (biospraymakassar.com)
- Of note, sometimes the neuroendocrine component of the cancer may be missed on a tissue biopsy and will not be made until more tissue is obtained, such as at the time of surgery. (damncancer.com)
- Also called Merkel cell cancer, neuroendocrine carcinoma of the skin, and trabecular cancer. (ronnyallan.net)
Tumour3
- He also believes in the next three years, oncologists will be able to determine which rare tumour types display a sensitivity to immune checkpoint blockade - which may include high-grade neuroendocrine carcinoma. (ecancer.org)
- We present a giant non-functioning neuroendocrine tumour of the pancreas successfully treated surgically. (termedia.pl)
- But alternately in several cases, if said tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma. (biospraymakassar.com)
Poor prognosis1
- Upper urinary tract neuroendocrine carcinoma (UUT-NEC) is extremely rare and has a poor prognosis. (urotoday.com)
Poorly differentiated carcinoma2
- Subsequently, fine-needle aspiration cytology (FNAC) of the right cervical mass was performed, and it suggested poorly differentiated carcinoma. (biomedcentral.com)
- Poorly differentiated carcinoma is the second most common type of CUP. (cancer.ca)
Atypical carcinoid1
- The 14 cases were classified into 3 subtypes: typical carcinoid in 2, atypical carcinoid in 5, and small cell neuroendocrine carcinoma in 7. (hindawi.com)
Type of neuroendocrine carcinoma2
- It is not yet known whether temozolomide and capecitabine may work better than cisplatin or carboplatin and etoposide in treating patients with this type of neuroendocrine carcinoma, called non-small cell neuroendocrine carcinoma. (centerwatch.com)
- A type of Neuroendocrine Carcinoma that forms on or just beneath the skin, usually in parts of the body that have been exposed to the sun. (ronnyallan.net)
Cases of neuroendocrine carcinoma2
- Two cases of neuroendocrine carcinoma of the gallbladder. (springermedizin.de)
- Our findings indicate that some cases of neuroendocrine carcinoma may be responsive to antiangiogenic agent apatinib. (alliedacademies.org)
Metastatic neuroendocrine1
- To assess the stable disease rate and duration, time to progression, median survival time, 1-year survival rate and toxicity in patients with metastatic neuroendocrine carcinomas given CCI-779. (knowcancer.com)